WO2022146015A1 - Method and device for calculating individualized probability of medication side effect - Google Patents

Method and device for calculating individualized probability of medication side effect Download PDF

Info

Publication number
WO2022146015A1
WO2022146015A1 PCT/KR2021/020126 KR2021020126W WO2022146015A1 WO 2022146015 A1 WO2022146015 A1 WO 2022146015A1 KR 2021020126 W KR2021020126 W KR 2021020126W WO 2022146015 A1 WO2022146015 A1 WO 2022146015A1
Authority
WO
WIPO (PCT)
Prior art keywords
side effect
probability
drug
subject
occurrence
Prior art date
Application number
PCT/KR2021/020126
Other languages
French (fr)
Korean (ko)
Inventor
강민규
Original Assignee
충북대학교병원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 충북대학교병원 filed Critical 충북대학교병원
Priority to CN202180094842.6A priority Critical patent/CN116888681A/en
Publication of WO2022146015A1 publication Critical patent/WO2022146015A1/en
Priority to US18/345,630 priority patent/US20240013930A1/en

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Definitions

  • the present disclosure relates to a method and an apparatus for estimating a personalized probability of a drug side effect, and more particularly, to a method and an apparatus for calculating an occurrence probability of a drug side effect based on an individual's experience taking a drug.
  • Drugs have the potential to cause various side effects to the user, but this is a statistical probability before individuals taking the drug, and the possibility that the side effect actually occurs to individuals taking the drug is different.
  • the probability of experiencing a side effect when taking the drug at a specific point in time may actually differ from person to person, depending on whether or not the person has experienced side effects in the past.
  • the doctor can inform the doctor of the side effects experienced by the individual and the doctor can exclude drugs that are likely to cause side effects from the prescription, but there is a problem in that it is difficult to apply to all drugs taken by the individual.
  • An embodiment of the present disclosure provides a method and apparatus for estimating the probability of occurrence of a drug side effect based on an individual's experience of taking a drug.
  • Another embodiment of the present disclosure provides a method and apparatus for estimating the probability of occurrence of a personalized drug side effect based on the occurrence or non-occurrence of a side effect when an individual takes a drug.
  • Another embodiment of the present disclosure provides a method and an apparatus for estimating the probability of occurrence of a drug side effect based on the intensity of the side effect when the individual takes the drug, the previous administration time, and the like.
  • the personalized drug side effect probability calculation method of the computing device is a method in which each step is performed by a computing device, the step of checking the drug taken by the subject, It may include the step of confirming the inputted experience of the side effect, and calculating the probability of occurrence of the subject's side effect in relation to the drug based on the subject's experience of the side effect.
  • the computing device for calculating the personalized drug side effect probability includes a processor and a memory that is functionally connected to the processor and stores at least one code executed by the processor, and the memory is executed by the processor confirms the drug taken by the subject, confirms the occurrence of side effects received from the subject according to the subject's taking of the drug, and determines the probability of occurrence of side effects of the subject in relation to the drug based on the subject's experience of side effects You can store the code that causes it to calculate.
  • the method and apparatus for calculating the probability of occurrence of a drug side effect allow an individual to easily identify a drug or a component of the drug that is likely to cause a side effect to themselves.
  • the method and apparatus for calculating the occurrence probability of a drug side effect can prevent secondary damage due to side effects by excluding side effects that may be caused by personally taking drugs.
  • the method and apparatus for calculating the probability of occurrence of a drug side effect may identify a drug or a component of the drug that is highly likely to cause a side effect to the individual from among various drugs taken by an individual.
  • FIG. 1 is a diagram illustrating an environment in which a method and an apparatus for calculating the occurrence probability of a drug side effect based on an individual's experience of taking a drug according to an embodiment of the present disclosure are implemented.
  • FIG. 2 is a block diagram illustrating a configuration of a user terminal according to an embodiment of the present disclosure.
  • FIG. 3 is a block diagram illustrating a configuration of a server device according to an embodiment of the present disclosure.
  • FIG. 4 is a flowchart for explaining a method of calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure.
  • FIG. 5 is a flowchart for explaining a method of calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure.
  • FIG. 6 is a diagram for briefly explaining drug side effect information of a drug side effect database according to an embodiment of the present disclosure.
  • FIGS. 7 and 8 are diagrams illustrating an individual's experience of side effects for explaining a method of calculating the probability of occurrence of drug side effects according to an embodiment of the present disclosure.
  • FIG. 9 is a diagram illustrating an interface of a user terminal according to an embodiment of the present disclosure.
  • FIG. 1 An environment for implementing a method or apparatus for calculating the occurrence probability of a drug side effect according to an embodiment of the present disclosure will be described with reference to FIG. 1 .
  • expressions of drug, drug, drug, etc. may be a drug composed of a single component or multiple components, and do not have different meanings.
  • dosing is a concept including cases of administration in the body in various forms, such as oral administration, administration through injections, administration through patches, skin application of ointments, and injection through nasal or eye mucosa.
  • the method or apparatus for calculating the probability of occurrence of a drug side effect may be implemented in a user terminal or a server device, and in the following description, it is described on the assumption that it is implemented in a server device, but it can be implemented in a user terminal should pay attention to
  • An environment for implementing the method or apparatus for calculating the occurrence probability of a drug side effect may include the user terminal device 100 and the server device 200 .
  • the database including the statistical side effect probability information of the drug is implemented as a separate device, the drug side effect database device 300 may be included.
  • the subject who has taken the drug may input the drug that he or she has taken, whether the side effect experienced after taking the drug, and the type of the side effect if it has occurred, through the user terminal 100 .
  • the server device 200 displays a component including the drug or side effects 920 related to the drug as side effects data. It may be obtained from the base 300 and provided to the user terminal 100 . The user may select a side effect that he or she has experienced from among the side effects provided or that no side effect has occurred, and the server device 200 determines whether or not the selected side effect occurs and the type of side effect included in the drug or drug taken by the user. The probability of occurrence of side effects of the user is updated with respect to the component.
  • the server device 200 obtains the statistical side effect probability of the drug taken by the user or a component included in the drug from the drug side effect database 300 or a database provided by itself, and is added to the user's corresponding drug or component included in the drug. It is set as the first personalized drug manager's probability for the first time, and the personalized drug side effect probability is recalculated (updated) for each drug taking experience of the user. The server device 200 recalculates the personalized drug side effect probability by reflecting the experience without side effects.
  • the server device 200 may receive a specific drug or a specific component from the user terminal 100 and provide a personalized drug side effect probability.
  • the server device 200 may provide this to the user terminal 100 when the probability of an individual side effect for a specific drug exceeds a preset threshold value or exceeds a preset criterion, such as the occurrence of side effects exceeds a preset consecutive number of times.
  • the user terminal 100 may be provided with a personalized drug side effect probability for a specific drug or a specific component from the server device 200, and may check this when the user purchases a specific drug.
  • a personalized drug side effect probability is provided for that specific patient's specific drug or specific ingredient, so that the patient has a high probability of experiencing side effects Drugs can be excluded.
  • the configuration of the user terminal 100 will be described with reference to FIG. 2 .
  • the user terminal 100 may include a communication interface for performing communication with the server device 200 .
  • the communication interface may include a wireless communication unit or a wired communication unit.
  • the wireless communication unit may include at least one of a mobile communication module, a wireless Internet module, a short-range communication module, and a location information module.
  • the mobile communication module includes technical standards or communication methods for mobile communication (eg, GSM (Global System for Mobile communication), CDMA (Code Division Multi Access), CDMA2000 (Code Division Multi Access 2000)), EV-DO (Enhanced Voice-Data Optimized or Enhanced Voice-Data Only), Wideband CDMA (WCDMA), High Speed Downlink Packet Access (HSDPA), High Speed Uplink Packet Access (HSUPA), Long Term Evolution (LTE), Long Term (LTE-A) Evolution-Advanced), etc.), transmits and receives radio signals to and from at least one of a base station, an external terminal, and a server on a mobile communication network.
  • GSM Global System for Mobile communication
  • CDMA Code Division Multi Access
  • CDMA2000 Code Division Multi Access 2000
  • EV-DO Enhanced Voice-Data Optimized or Enhanced Voice-Data Only
  • WCDMA Wideband CDMA
  • HSDPA High Speed Downlink Packet Access
  • HSUPA High Speed Uplink Packet Access
  • LTE Long Term Evolution
  • the wireless Internet module refers to a module for wireless Internet access, and may be built-in or external to the user terminal 100 .
  • the wireless Internet module is configured to transmit and receive wireless signals in a communication network according to wireless Internet technologies.
  • WLAN Wireless LAN
  • Wi-Fi Wireless-Fidelity
  • Wi-Fi Wireless Fidelity
  • DLNA Digital Living Network Alliance
  • WiBro Wireless Broadband
  • WiMAX Worldwide Interoperability for Microwave Access
  • HSDPA High Speed Downlink Packet Access
  • HSUPA High Speed Uplink Packet Access
  • LTE Long Term Evolution
  • LTE-A Long Term Evolution-Advanced
  • the short-range communication module is for short-range communication, and includes BluetoothTM, Radio Frequency Identification (RFID), Infrared Data Association (IrDA), Ultra Wideband (UWB), ZigBee, and Near Field (NFC). Communication), Wi-Fi (Wireless-Fidelity), Wi-Fi Direct, and Wireless USB (Wireless Universal Serial Bus) technology may be used to support short-distance communication.
  • RFID Radio Frequency Identification
  • IrDA Infrared Data Association
  • UWB Ultra Wideband
  • ZigBee Ultra Wideband
  • NFC Near Field
  • Wi-Fi Wireless-Fidelity
  • Wi-Fi Direct Wireless USB (Wireless Universal Serial Bus) technology may be used to support short-distance communication.
  • the location information module is a module for acquiring the location (or current location) of the user terminal 100 , and a representative example thereof includes a Global Positioning System (GPS) module or a Wireless Fidelity (WiFi) module.
  • GPS Global Positioning System
  • WiFi Wireless Fidelity
  • the terminal may acquire the location of the user terminal 100 using a signal transmitted from a GPS satellite.
  • the user terminal 100 may include an input unit for inputting the user's drug type, side effect type, and the like.
  • the input unit may include a microphone for receiving an audio signal and a user input unit for receiving information from a user.
  • the user input unit may include a mechanical input means (or a mechanical key, a button, a dome switch, a jog wheel, a jog switch, etc.) and a touch input means.
  • the touch input means consists of a virtual key, a soft key, or a visual key displayed on the touch screen through software processing, or a part other than the touch screen. It may be made of a touch key (touch key) disposed on the.
  • the user terminal 100 may include an output unit for transmitting information to the user.
  • the output unit is for generating an output related to visual, auditory or tactile sense, and may include at least one of a display unit, a sound output unit, and an optical output unit.
  • the display unit displays (outputs) information processed by the user terminal 100 .
  • the display unit may display a drug provided from the server device 200 in relation to the drug taken by the user or the type of side effects of components included in the drug.
  • the sound output unit may include at least one of a receiver, a speaker, and a buzzer.
  • the user terminal 100 may include an interface unit that serves as a passage with various types of external devices connected to the user terminal 100 .
  • the interface unit includes a wired/wireless data port, a memory card port, a port for connecting a device equipped with an identification module, an audio I/O (Input/Output) port, a video I It may include at least one of an /O (Input/Output) port and an earphone port.
  • a configuration of the server device 200 according to an embodiment of the present disclosure will be described with reference to FIG. 3 .
  • the server device 200 includes the subject's body information, a diagnosis name (which may be a diagnostic code) when prescribing the subject's drug, the type of drug taken or the type of component included in the drug, the dose and time information of each drug, each When taking a drug, it is possible to store whether or not any side effects experienced or the type of side effects.
  • a diagnosis name which may be a diagnostic code
  • the server device 200 may store the drug or statistical side effect information of the components included in the drug, and the component information of the drug.
  • the server device 200 may store medical treatment information including a patient's diagnosis disease name (which may be a diagnosis code), prescription information, or body information.
  • medical treatment information including a patient's diagnosis disease name (which may be a diagnosis code), prescription information, or body information.
  • the information stored by the server device 200 may be implemented as an external separate database or may be implemented as a storage device 240 that is a part of the server device 200 .
  • the server device 200 is based on the type of drug the user has taken, whether side effects occur, and the type of side effects, provided from the user terminal 100 through the communication interface 230, and is based on the component information of the drug and the drug or ingredients included in the drug. Using the statistical side effect information, the processor 210 may calculate the user's personalized drug side effect probability.
  • the processor 210 of the server device 200 may calculate the user's personalized drug side effect probability based on the occurrence as well as the non-occurrence of side effects after the user takes the drug, and in this case, the user's personalized drug side effect probability Algorithms for calculating ? can be applied differently.
  • the algorithm for estimating the user's personalized drug side effect probability may be implemented in hardware, software, or a combination of hardware and software. can be stored in
  • a method of calculating a personalized drug side effect probability according to an embodiment of the present disclosure will be described with reference to FIG. 4 .
  • the method for estimating the personalized drug side effect probability can be implemented in the user terminal, but the following description is based on the assumption that it is implemented in the server device.
  • the server device 200 checks the medication taken by the user input by the user in the user terminal 100 (S110).
  • the drug taken by the user may be a drug composed of a single component or a drug composed of a plurality of components, and may be a plurality of drugs taken at the same time or within a predetermined time.
  • the drug may be a product name input through a user input, or by recognizing a product name on a product packaging paper or by recognizing a code such as a QR code on a product packaging paper through the camera device of the user terminal 100 .
  • the server device 200 may check a diagnosis name or a diagnosis code printed on a prescription in a similar manner, or may check a diagnosis name or a diagnosis code by accessing a separate medical information system (OCS, HIS, EMR, etc.).
  • OCS separate medical information system
  • the server device 200 may check whether the user has side effects according to the taking of the drug or the side effects experience including the type of side effects (S120).
  • the server device 200 calculates the probability of occurrence of side effects of the user for the individual medications taken based on the user's experience of side effects (S130).
  • the server device 200 obtains a statistical side effect probability as shown in FIG. 6 of the drug or a component included in the drug from the database, and determines the user's basic side effect probability for the drug
  • the probability of drug side effects is calculated based on the user's experience of side effects set and confirmed.
  • the side effect experience includes the non-occurrence of side effects
  • the server device 200 calculates the drug side effect probability based on the user's side effects experience by reflecting the user's experience that side effects do not occur after taking a specific drug. Therefore, the server device 200 includes the occurrence or non-occurrence of side effects after taking the drug, that is, whenever the user experiences taking the same drug or the experience of taking the drug containing the same component is input. For all experiences, the probability of occurrence of side effects of the user is updated with respect to the drug or a component included in the drug.
  • the server device 200 applies different algorithms to the experience of occurrence or non-occurrence of side effects after the user takes the drug to calculate the probability of occurrence of side effects of the user with respect to the corresponding drug, which will be described in detail below.
  • a detailed method ( S130 ) of calculating a personalized drug side effect probability according to an embodiment of the present disclosure will be described with reference to FIG. 5 .
  • the server device 200 applies different algorithms to the experience of occurrence or non-occurrence of side effects after the user takes the drug to calculate the probability of occurrence of side effects of the user with respect to the corresponding drug, and when no side effects occur It is possible to reduce the probability of occurrence of side effects of the user with respect to the drug or component of the drug (S132).
  • the server device 200 may reduce the increase or decrease in the probability of occurrence of side effects of the user for each component when a drug composed of a complex component or a plurality of drugs is taken.
  • the algorithm for increasing or decreasing the probability of a specific side effect includes a case in which the probability of a specific side effect is increased or decreased equally by dividing by the number of drugs taken, or a weight is applied to the probability of occurrence of a previous side effect and reflected.
  • the server device 200 acquires a statistical side effect probability as shown in FIG. 6 and sets it as the user's basic side effect probability for the corresponding drug. For example, referring to FIG. 6 , the probability of occurrence of a statistical side effect for symptom 1 of component A is 10%, and the probability of occurrence of a statistical side effect for symptom 2 is 5%. Thereafter, the server device 200 may multiply the basic side effect probability by a preset disincentive constant that reflects the user's experience of not generating side effects, and the disincentive constant may be less than 1 and may be determined experimentally.
  • the server device 200 determines the symptom 1 for component A of the user.
  • the server device 200 determines the user for each symptom of components A and B using the same inverse compensation constant based on the previously calculated probability of occurrence of side effects of the user. It is possible to recalculate (update) the probability of occurrence of side effects.
  • the server device 200 may check the user's disease (S133).
  • the server device 200 may check prescription information in which the patient's disease code is recorded in an Electronic Medical Record (EMR) server or through a user's input.
  • EMR Electronic Medical Record
  • the EMR server is a concept including a medical record management server managed by a public institution, as well as a medical record management or delivery server managed by a private institution to share or deliver the medical records of each hospital.
  • the user may recognize or directly input the disease code printed on the prescription through the camera device of the user terminal 100 from the prescription.
  • the server device 200 may check the symptoms of the user's disease (S134), obtain the statistical side effect probability of the drug or the drug taken by the patient as shown in FIG. 6, and compare them with each other (S135).
  • the server device 200 may not reflect the corresponding side effect experience in calculating the user's drug side effect probability. Accordingly, it is possible to exclude a case in which the user incorrectly calculates the probability of a side effect by mistaking the symptom of a disease as the occurrence of a side effect due to taking the drug.
  • the server device 200 may increase the probability of occurrence of the side effects of the user for each component of the medication taken (S136).
  • the server device 200 When a user takes a specific drug for the first time and side effects do not occur, the server device 200 obtains a statistical side effect probability as shown in FIG. 6 and sets it as the user's basic side effect probability for the corresponding drug, and then the server device 200 ) may be multiplied by a preset incentive constant that reflects the user's experience in generating side effects to the basic side effect probability, and the reward constant may be greater than 1 and may be determined experimentally.
  • symptom 1 is The method of recalculating (updating) the probability of drug side effects for the case where symptom 2 has not occurred will be described.
  • the server device 200 may update the drug side effect probability by applying the inverse compensation constant and the compensation constant to the user's stored side effect probability for component A and component B.
  • FIG. 7(b) updates the drug side effect occurrence probability after taking another drug containing component A.
  • symptom 1 occurs and symptom 2 does not occur as shown in FIG. 8 (b) after a user, such as the user of FIG.
  • Methods for reestimating (updating) the probability of adverse drug reactions are described.
  • the personalized side effect probability By applying the reward constant 1.5 to the personalized side effect probability of 22.5% for symptom 1 of component A stored in advance for the current user 'A', the personalized side effect probability can be updated to a side effect probability of 33.75%, and the pre-stored component A By applying the inverse reward constant 0.5 to the personalized side effect probability of 3.75% for symptom 2 of , the personalized side effect probability can be updated with a side effect probability of 1.875%.
  • the reward constant 1.5 is applied to 10% of the statistical side effect probability for symptom 1 of component C to calculate the personalized side effect probability for component C as 15%.
  • the initial value may be set to an arbitrary specific constant value (which may be very small) in terms of implementation. have.
  • the user can acquire a personalized side effect occurrence probability as the experience of taking different drugs with some overlapping components is accumulated, and determine the drug to avoid based on this.
  • the server device 200 may set the compensation constant differently for each component based on the statistical side effect probability of the drug or a component included in the drug.
  • the compensation constant for symptom 1 of component A may be set lower than the compensation constant for symptom 1 of component B. Accordingly, it is possible to obtain a personalized side effect occurrence probability by reflecting different statistical probabilities even for a plurality of components having the same side effect symptom.
  • the server device 200 may set the compensation constant differently based on the consecutive number of times the user experiences the same side effect after taking the same ingredient.
  • the server device 200 may set a compensation constant when symptom 1 of component A is continuously experienced a second time to be larger than a compensation constant when symptom 1 of component A is first experienced. Therefore, as the experience of taking different drugs is accumulated, it is possible to obtain a more precisely personalized probability of occurrence of side effects.
  • the server device 200 may set the compensation constant differently based on the intensity of the side effect experienced by the user.
  • the server device 200 may set the compensation constant when the symptom 1 of the component A is experienced with the intensity 2 to be larger than the compensation constant when the symptom 1 of the component A is experienced with the intensity 1.
  • the server device 200 may provide the user terminal 100 with an interface for selecting the intensity of the side effect experienced by the user. Accordingly, as the experience of taking drugs is accumulated, it is possible to obtain a more precisely personalized probability of occurrence of side effects.
  • the server device 200 when the drug blood concentration of the drug previously taken by the user is higher than or equal to a certain level, that is, when it is determined that the drug previously taken remains in the body, the server device 200 is for calculating the probability of side effects of the drug. can be excluded from experience.
  • the server device 200 checks the time the user previously took the drug containing component A, calculates the blood concentration of component A based on the user's body information set in advance, and the blood concentration is preset In the case of exceeding the standard, even if a side effect occurs, it can be excluded from the experience for estimating the probability of a drug side effect. Therefore, it is possible to exclude that the side effects experience of the drug is increased due to the overlapping experience of side effects due to the previous administration.
  • the present disclosure described above can be implemented as computer-readable code on a medium in which a program is recorded.
  • the computer-readable medium includes all types of recording devices in which data readable by a computer system is stored. Examples of computer-readable media include Hard Disk Drive (HDD), Solid State Disk (SSD), Silicon Disk Drive (SDD), ROM, RAM, CD-ROM, magnetic tape, floppy disk, optical data storage device, etc. There is this.
  • the computer may include a processor of a user terminal or a server device.
  • the program may be specially designed and configured for the present disclosure, or may be known and used by those skilled in the art of computer software.
  • Examples of the program may include not only machine code generated by a compiler, but also high-level language code that can be executed by a computer using an interpreter or the like.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

A method for calculating an individualized probability of a medication side effect by means of a computing device according to an embodiment disclosed herein may comprise the steps of: confirming the medication taken by a subject; confirming the subject's experience of a side effect as a result of taking the medication, which was received as an input from the subject; and calculating the probability of the side effect occurring in the subject in relation to the medication on the basis of the experience of the side effect by the subject, wherein each of the steps is performed by the computing device.

Description

약물 부작용의 개인화된 확률을 산정하는 방법 및 장치Method and Apparatus for Estimating Personalized Probability of Drug Side Effects
본 개시는 약물 부작용의 개인화된 확률을 산정하는 방법 및 장치에 관한 것으로서, 더욱 상세하게는 개인의 약물 복용 경험에 기반하여 약물 부작용의 발생 확률을 산정하는 방법 및 장치에 관한 것이다.The present disclosure relates to a method and an apparatus for estimating a personalized probability of a drug side effect, and more particularly, to a method and an apparatus for calculating an occurrence probability of a drug side effect based on an individual's experience taking a drug.
개인들은 병원에서 처방 받은 약제를 복용하거나 개인의 판단 또는 약사의 조언에 따라 다양한 약제들을 복용하고 있다.Individuals are taking medications prescribed by a hospital or taking various medications according to the individual's judgment or the advice of a pharmacist.
약제들은 복용자에게 다양한 부작용을 초래할 수 있는 가능성을 가지고 있지만, 이는 개인들이 해당 약물을 복용하기 전의 통계적인 확률로서 약제를 복용하는 개개인에게 부작용이 실제 발생하는 가능성은 서로 다르다. 동일한 약제를 이전 여러 차례 복용한 경험이 있을 때, 과거 부작용 경험 여부에 따라 특정 시점에서 약을 복용했을 때 부작용을 경험할 확률은 개인마다 실제로 다를 수 있다.Drugs have the potential to cause various side effects to the user, but this is a statistical probability before individuals taking the drug, and the possibility that the side effect actually occurs to individuals taking the drug is different. When taking the same drug multiple times before, the probability of experiencing a side effect when taking the drug at a specific point in time may actually differ from person to person, depending on whether or not the person has experienced side effects in the past.
즉, 동일한 통계적 부작용 확률을 가진 동일한 약제를 복용한 서로 다른 개인들 중 결과적으로 어느 복용자는 해당 부작용을 경험할 수 있지만, 다른 복용자는 해당 부작용을 경험하지 않을 수 있고, 약물의 특정 성분의 통계적 부작용 발생 확률이 높음에도 불구하고, 특정 복용자는 해당 약물의 부작용이 발생하지 않는 신체적 조건일 수도 있다. That is, among different individuals taking the same drug with the same statistical side effect probability, one user may experience the side effect as a result, but the other user may not experience the side effect, and the statistical side effect of a particular component of the drug may occur. Despite the high probability, certain users may have physical conditions that do not cause side effects of the drug.
하지만, 질환에 대해 다양한 약재로 구성된 약제를 복용하거나 또는 다양한 약제를 복용하는 경우, 각 개인들은 경험한 부작용이 어떤 약물로 인한 것인지 혹은 약물에 포함된 어떤 성분에 의한 것인지 알기 어렵다. 따라서, 개인이 경험한 부작용을 다시 경험하지 않기 위하여 자신에게 부작용을 초래한 약제 또는 성분을 회피하기 어려운 문제점이 있다.However, when taking a drug composed of various drugs or taking a variety of drugs for a disease, it is difficult for each individual to know whether the side effect experienced by the drug is caused by the drug or the component contained in the drug. Therefore, there is a problem in that it is difficult to avoid the drug or component that caused the side effect to the individual so as not to experience the side effect again.
병원에서 처방 받는 경우, 개인이 경험한 부작용을 의사에게 알려주고 의사가 부작용을 일으킬 가능성이 있는 약제를 처방에서 제외할 수 있으나, 개인이 복용하는 모든 약제에 대해서 적용하기 어려운 문제점이 있다.When prescribed in a hospital, the doctor can inform the doctor of the side effects experienced by the individual and the doctor can exclude drugs that are likely to cause side effects from the prescription, but there is a problem in that it is difficult to apply to all drugs taken by the individual.
종래 기술로서 개인이 경험한 부작용이 있는 약을 처방에서 제외하는 기술이 존재하지만, 앞서 설명한 것처럼 다양한 약제를 복용한 개인이 어떤 약물로 해당 부작용이 발생했는지 알기 어렵고, 의사의 처방이 아닌 약제를 복용할 경우 이를 적용하기 어려운 문제점이 있다.As a prior art, there is a technique that excludes from prescription drugs with side effects experienced by individuals, but as described above, it is difficult for individuals who have taken various drugs to know which side effects occurred with which drugs, and taking drugs other than those prescribed by a doctor. There is a problem in that it is difficult to apply this.
최근, 개인의 유전자에 기반하여 약물 부작용 가능성을 산출하거나 개인의 생리학적 특징에 기반하여 약물 부작용 가능성을 산출하는 시도가 있으나, 아직 공식적인 개인화된 부작용 확률 기술로 인정받지 못하고 있으며 경제적으로나 방법적으로 개인이 접근하기 어려운 실정이다.Recently, attempts have been made to calculate the possibility of drug side effects based on individual genes or to calculate the possibility of drug side effects based on individual physiological characteristics, but it is not yet recognized as an official personalized side effect probability technique, and it is economically and methodically This is difficult to access.
따라서, 과학적으로 골드 스탠다드에 해당하는 정확한 확률은 아닐지라도, 개인이 자신에게 부작용이 발생할 가능성이 높은 약물을 용이하게 파악할 수 있는 기술이 필요하다.Therefore, although it is not scientifically accurate probability corresponding to the gold standard, there is a need for a technology that allows an individual to easily identify a drug with a high probability of causing side effects.
본 개시의 일 실시 예는 개인의 약물 복용 경험에 기반하여 약물 부작용의 발생 확률을 산정하는 방법 및 장치를 제공한다. An embodiment of the present disclosure provides a method and apparatus for estimating the probability of occurrence of a drug side effect based on an individual's experience of taking a drug.
본 개시의 다른 실시 예는 개인의 약물 복용 시의 부작용의 발생 또는 미 발생에 기반하여 개인화된 약물 부작용의 발생 확률을 산정하는 방법 및 장치를 제공한다.Another embodiment of the present disclosure provides a method and apparatus for estimating the probability of occurrence of a personalized drug side effect based on the occurrence or non-occurrence of a side effect when an individual takes a drug.
본 개시의 다른 실시 예는 개인의 약물 복용 시의 부작용의 강도, 이전 복용 시기 등에 기반하여 약물 부작용의 발생 확률을 산정하는 방법 및 장치를 제공한다.Another embodiment of the present disclosure provides a method and an apparatus for estimating the probability of occurrence of a drug side effect based on the intensity of the side effect when the individual takes the drug, the previous administration time, and the like.
본 발명이 해결하고자 하는 과제는 이상에서 언급한 과제에 한정되지 않으며, 언급되지 않은 본 발명의 다른 과제 및 장점들은 하기의 설명에 의해서 이해될 수 있고, 본 발명의 실시 예에 의해보다 분명하게 이해될 것이다. 또한, 본 발명이 해결하고자 하는 과제 및 장점들은 특허 청구 범위에 나타낸 수단 및 그 조합에 의해 실현될 수 있음을 알 수 있을 것이다.The problem to be solved by the present invention is not limited to the above-mentioned problems, and other problems and advantages of the present invention not mentioned can be understood by the following description, and more clearly understood by the embodiments of the present invention will be In addition, it will be understood that the problems and advantages to be solved by the present invention can be realized by means and combinations thereof indicated in the claims.
본 개시의 일 실시 예에 따른 컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법은 각 단계가 컴퓨팅 장치에 의해 수행되는 방법으로서, 대상자가 복용한 약제를 확인하는 단계, 대상자의 약제의 복용에 따라 대상자로부터 입력 받은 부작용의 경험을 확인하는 단계, 대상자의 부작용의 경험에 기반하여 약제와 관련하여 대상자의 부작용의 발생 확률을 산정하는 단계를 포함할 수 있다. The personalized drug side effect probability calculation method of the computing device according to an embodiment of the present disclosure is a method in which each step is performed by a computing device, the step of checking the drug taken by the subject, It may include the step of confirming the inputted experience of the side effect, and calculating the probability of occurrence of the subject's side effect in relation to the drug based on the subject's experience of the side effect.
본 개시의 일 실시 예에 따른 개인화된 약물 부작용 확률을 산정하는 컴퓨팅 장치는 프로세서 및 프로세서와 기능적으로 연결되고 프로세서에서 수행되는 적어도 하나의 코드가 저장되는 메모리를 포함하고, 메모리는 프로세서에서 실행될 때 프로세서로 하여금 대상자가 복용한 약제를 확인하고, 대상자의 상기 약제의 복용에 따른 상기 대상자로부터 입력 받은 부작용의 발생을 확인하고, 대상자의 부작용의 경험에 기반하여 약제와 관련하여 대상자의 부작용의 발생 확률을 산정하도록 야기하는 코드를 저장할 수 있다.The computing device for calculating the personalized drug side effect probability according to an embodiment of the present disclosure includes a processor and a memory that is functionally connected to the processor and stores at least one code executed by the processor, and the memory is executed by the processor confirms the drug taken by the subject, confirms the occurrence of side effects received from the subject according to the subject's taking of the drug, and determines the probability of occurrence of side effects of the subject in relation to the drug based on the subject's experience of side effects You can store the code that causes it to calculate.
본 개시의 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법 및 장치는 개인이 용이하게 자신에게 부작용을 일으킬 가능성이 큰 약물 또는 약물의 성분을 파악할 수 있다.The method and apparatus for calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure allow an individual to easily identify a drug or a component of the drug that is likely to cause a side effect to themselves.
본 개시의 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법 및 장치는 개인적으로 복용하는 약물이 초래할 수 있는 부작용을 배제시킴으로써 부작용으로 인한 2차적 피해를 예방할 수 있다.The method and apparatus for calculating the occurrence probability of a drug side effect according to an embodiment of the present disclosure can prevent secondary damage due to side effects by excluding side effects that may be caused by personally taking drugs.
본 개시의 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법 및 장치는 개인이 복용한 다양한 약물 중에서 자신에게 부작용을 일으킬 가능성이 높은 약물 또는 약물의 성분을 파악할 수 있다.The method and apparatus for calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure may identify a drug or a component of the drug that is highly likely to cause a side effect to the individual from among various drugs taken by an individual.
본 발명의 효과는 이상에서 언급된 것들에 한정되지 않으며, 언급되지 아니한 다른 효과들은 아래의 기재로부터 통상의 기술자에게 명확하게 이해될 수 있을 것이다.Effects of the present invention are not limited to those mentioned above, and other effects not mentioned will be clearly understood by those skilled in the art from the following description.
도 1은 본 개시의 일 실시 예에 따른 개인의 약물 복용 경험에 기반하여 약물 부작용의 발생 확률을 산정하는 방법 및 장치가 구현되는 환경을 나타낸 도면이다.1 is a diagram illustrating an environment in which a method and an apparatus for calculating the occurrence probability of a drug side effect based on an individual's experience of taking a drug according to an embodiment of the present disclosure are implemented.
도 2는 본 개시의 일 실시 예에 따른 사용자 단말기의 구성을 나타낸 블록도이다.2 is a block diagram illustrating a configuration of a user terminal according to an embodiment of the present disclosure.
도 3은 본 개시의 일 실시 예에 따른 서버 장치의 구성을 나타낸 블록도이다.3 is a block diagram illustrating a configuration of a server device according to an embodiment of the present disclosure.
도 4는 본 개시의 일 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법을 설명하기 위한 순서도이다.4 is a flowchart for explaining a method of calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure.
도 5는 본 개시의 일 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법을 설명하기 위한 순서도이다.5 is a flowchart for explaining a method of calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure.
도 6은 본 개시의 일 실시 예에 따른 약물 부작용 데이터 베이스의 약물 부작용 정보를 간략하게 설명하기 위한 도면이다.6 is a diagram for briefly explaining drug side effect information of a drug side effect database according to an embodiment of the present disclosure.
도 7 및 도 8은 본 개시의 일 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법을 설명하기 위한 개인의 부작용 경험을 도시한 도면이다.7 and 8 are diagrams illustrating an individual's experience of side effects for explaining a method of calculating the probability of occurrence of drug side effects according to an embodiment of the present disclosure.
도 9는 본 개시의 일 실시 예에 따른 사용자 단말기의 인터페이스를 도시한 도면이다.9 is a diagram illustrating an interface of a user terminal according to an embodiment of the present disclosure.
이하, 첨부된 도면을 참조하여 본 명세서에 개시된 실시 예를 상세히 설명하되, 도면 부호에 관계없이 동일하거나 유사한 구성요소는 동일한 참조 번호를 부여하고 이에 대한 중복되는 설명은 생략하기로 한다. 이하의 설명에서 사용되는 구성요소에 대한 접미사 "모듈" 및 "부"는 명세서 작성의 용이함만이 고려되어 부여되거나 혼용되는 것으로서, 그 자체로 서로 구별되는 의미 또는 역할을 갖는 것은 아니다. 또한, 본 명세서에 개시된 실시 예를 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 명세서에 개시된 실시 예의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다. 또한, 첨부된 도면은 본 명세서에 개시된 실시 예를 쉽게 이해할 수 있도록 하기 위한 것일 뿐, 첨부된 도면에 의해 본 명세서에 개시된 기술적 사상이 제한되지 않으며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.Hereinafter, the embodiments disclosed in the present specification will be described in detail with reference to the accompanying drawings, but the same or similar components are assigned the same reference numbers regardless of reference numerals, and redundant description thereof will be omitted. The suffixes "module" and "part" for components used in the following description are given or mixed in consideration of only the ease of writing the specification, and do not have distinct meanings or roles by themselves. In addition, in describing the embodiments disclosed in the present specification, if it is determined that detailed descriptions of related known technologies may obscure the gist of the embodiments disclosed in this specification, the detailed description thereof will be omitted. In addition, the accompanying drawings are only for easy understanding of the embodiments disclosed in the present specification, and the technical idea disclosed herein is not limited by the accompanying drawings, and all changes included in the spirit and scope of the present invention , should be understood to include equivalents or substitutes.
제1, 제2 등과 같이 서수를 포함하는 용어는 다양한 구성요소들을 설명하는데 사용될 수 있지만, 상기 구성요소들은 상기 용어들에 의해 한정되지는 않는다. 상기 용어들은 하나의 구성요소를 다른 구성요소로부터 구별하는 목적으로만 사용된다.Terms including an ordinal number such as 1st, 2nd, etc. may be used to describe various elements, but the elements are not limited by the terms. The above terms are used only for the purpose of distinguishing one component from another.
어떤 구성요소가 다른 구성요소에 "연결되어" 있다거나 "접속되어" 있다고 언급된 때에는, 그 다른 구성요소에 직접적으로 연결되어 있거나 또는 접속되어 있을 수도 있지만, 중간에 다른 구성요소가 존재할 수도 있다고 이해되어야 할 것이다. 반면에, 어떤 구성요소가 다른 구성요소에 "직접 연결되어" 있다거나 "직접 접속되어" 있다고 언급된 때에는, 중간에 다른 구성요소가 존재하지 않는 것으로 이해되어야 할 것이다.When an element is referred to as being “connected” or “connected” to another element, it is understood that it may be directly connected or connected to the other element, but other elements may exist in between. it should be On the other hand, when it is said that a certain element is "directly connected" or "directly connected" to another element, it should be understood that the other element does not exist in the middle.
도 1을 참조하여 본 개시의 일 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법 또는 장치를 구현하기 위한 환경을 설명한다.An environment for implementing a method or apparatus for calculating the occurrence probability of a drug side effect according to an embodiment of the present disclosure will be described with reference to FIG. 1 .
본 명세서에서 약제, 약물, 약품 등의 표현은 단일 성분 또는 복합 성분으로 구성된 약일 수 있고 서로 다른 의미를 가지지 않는다. In the present specification, expressions of drug, drug, drug, etc. may be a drug composed of a single component or multiple components, and do not have different meanings.
본 명세서에서 복용은 구강 복용뿐만 아니라, 주사제를 통한 복용, 패치를 통한 복용, 연고제의 피부 도포, 비강 또는 눈 점막을 통한 주입 등 다양한 형태로 체내에 투약되는 경우를 포함하는 개념이다. In the present specification, dosing is a concept including cases of administration in the body in various forms, such as oral administration, administration through injections, administration through patches, skin application of ointments, and injection through nasal or eye mucosa.
본 개시의 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법 또는 장치는 사용자 단말기 또는 서버 장치로 구현될 수 있으며, 아래의 설명에서는 서버 장치에서 구현되는 것을 전제로 하여 설명하지만 사용자 단말기에서 구현 가능함을 주의해야 한다.The method or apparatus for calculating the probability of occurrence of a drug side effect according to an embodiment of the present disclosure may be implemented in a user terminal or a server device, and in the following description, it is described on the assumption that it is implemented in a server device, but it can be implemented in a user terminal should pay attention to
본 개시의 실시 예에 따른 약물 부작용의 발생 확률을 산정하는 방법 또는 장치를 구현하기 위한 환경은 사용자 단말 장치(100) 및 서버 장치(200)를 포함할 수 있다. 약물의 통계적인 부작용 확률 정보가 포함된 데이터 베이스가 별개의 장치로 구현되는 경우, 약물 부작용 데이터 베이스 장치(300)가 포함될 수 있다.An environment for implementing the method or apparatus for calculating the occurrence probability of a drug side effect according to an embodiment of the present disclosure may include the user terminal device 100 and the server device 200 . When the database including the statistical side effect probability information of the drug is implemented as a separate device, the drug side effect database device 300 may be included.
약제를 복용한 대상자는 사용자 단말기(100)를 통해 자신이 복용한 약물 및 해당 약물의 복용 이후에 경험한 부작용의 발생 여부와 발생하였다면 해당 부작용의 종류를 입력할 수 있다.The subject who has taken the drug may input the drug that he or she has taken, whether the side effect experienced after taking the drug, and the type of the side effect if it has occurred, through the user terminal 100 .
도 9를 참조하면, 사용자가 복용한 약물(910)을 사용자 단말기(100)에 입력하면, 서버 장치(200)는 해당 약물이 포함된 성분 또는 해당 약물과 관련된 부작용들(920)을 약물 부작용 데이터 베이스(300)에서 획득하여 이를 사용자 단말기(100)에 제공할 수 있다. 사용자는 제공 받은 부작용 들 중에서 자신이 경험한 부작용을 선택하거나 부작용이 발생하지 않았음을 선택할 수 있고, 서버 장치(200)는 선택된 부작용 발생 여부 및 부작용 종류는 사용자가 복용한 약물 또는 약물에 포함된 성분에 대하여 사용자의 부작용 발생 확률을 갱신한다.Referring to FIG. 9 , when a user inputs a drug 910 taken by the user into the user terminal 100 , the server device 200 displays a component including the drug or side effects 920 related to the drug as side effects data. It may be obtained from the base 300 and provided to the user terminal 100 . The user may select a side effect that he or she has experienced from among the side effects provided or that no side effect has occurred, and the server device 200 determines whether or not the selected side effect occurs and the type of side effect included in the drug or drug taken by the user. The probability of occurrence of side effects of the user is updated with respect to the component.
서버 장치(200)는 사용자가 복용한 약물 또는 약물에 포함된 성분의 통계적 부작용 확률을 약물 부작용 데이터 베이스(300) 또는 자체적으로 구비한 데이터 베이스에서 획득하여 사용자의 해당 약물 또는 약물에 포함된 성분에 대한 최초 개인화된 약물 부장용 확률로 설정하고, 사용자의 약물 복용 경험마다 개인화된 약물 부작용 확률을 재 산정(갱신)한다. 서버 장치(200)는 부작용이 없는 경험도 이를 반영하여 개인화된 약물 부작용 확률을 재 산정한다.The server device 200 obtains the statistical side effect probability of the drug taken by the user or a component included in the drug from the drug side effect database 300 or a database provided by itself, and is added to the user's corresponding drug or component included in the drug. It is set as the first personalized drug manager's probability for the first time, and the personalized drug side effect probability is recalculated (updated) for each drug taking experience of the user. The server device 200 recalculates the personalized drug side effect probability by reflecting the experience without side effects.
서버 장치(200)는 사용자 단말기(100)로부터 특정 약물 또는 특정 성분을 제공 받고 이에 대한 개인화된 약물 부작용 확률을 제공할 수 있다.The server device 200 may receive a specific drug or a specific component from the user terminal 100 and provide a personalized drug side effect probability.
서버 장치(200)는 특정 약물에 대한 개인의 부작용 확률이 미리 설정된 임계값을 넘어서거나 부작용 발생이 미리 설정된 연속 회수를 넘어서는 등 미리 설정된 기준을 넘어서는 경우 이를 사용자 단말기(100)에 제공할 수 있다.The server device 200 may provide this to the user terminal 100 when the probability of an individual side effect for a specific drug exceeds a preset threshold value or exceeds a preset criterion, such as the occurrence of side effects exceeds a preset consecutive number of times.
사용자 단말기(100)는 서버 장치(200)로부터 특정 약물 또는 특정 성분에 대해 개인화된 약물 부작용 확률을 제공받아 사용자가 특정 약물을 구입할 때 이를 확인할 수 있다. 다른 방법으로, 약국 또는 병원의 단말기에서 특정 환자에게 약물을 처방 또는 조제 또는 판매 시에 해당 특정 환자의 특정 약물 또는 특정 성분에 대해 개인화된 약물 부작용 확률을 제공받아 해당 환자에게 부작용이 발생할 확률이 높은 약물을 배제할 수 있다.The user terminal 100 may be provided with a personalized drug side effect probability for a specific drug or a specific component from the server device 200, and may check this when the user purchases a specific drug. Alternatively, when prescribing, dispensing, or selling a drug to a specific patient at a pharmacy or hospital terminal, a personalized drug side effect probability is provided for that specific patient's specific drug or specific ingredient, so that the patient has a high probability of experiencing side effects Drugs can be excluded.
도 2를 참조하여 사용자 단말기(100)의 구성을 설명한다.The configuration of the user terminal 100 will be described with reference to FIG. 2 .
사용자 단말기(100)는 서버 장치(200)와 통신을 수행하기 위한 통신 인터페이스를 포함할 수 있다.The user terminal 100 may include a communication interface for performing communication with the server device 200 .
통신 인터페이스는 무선 통신부 또는 유선 통신부를 포함할 수 있다.The communication interface may include a wireless communication unit or a wired communication unit.
무선 통신부는, 이동통신 모듈, 무선 인터넷 모듈, 근거리 통신 모듈, 위치정보 모듈 중 적어도 하나를 포함할 수 있다.The wireless communication unit may include at least one of a mobile communication module, a wireless Internet module, a short-range communication module, and a location information module.
이동통신 모듈은, 이동통신을 위한 기술표준들 또는 통신방식(예를 들어, GSM(Global System for Mobile communication), CDMA(Code Division Multi Access), CDMA2000(Code Division Multi Access 2000), EV-DO(Enhanced Voice-Data Optimized or Enhanced Voice-Data Only), WCDMA(Wideband CDMA), HSDPA(High Speed Downlink Packet Access), HSUPA(High Speed Uplink Packet Access), LTE(Long Term Evolution), LTE-A(Long Term Evolution-Advanced) 등)에 따라 구축된 이동 통신망 상에서 기지국, 외부의 단말, 서버 중 적어도 하나와 무선 신호를 송수신한다. The mobile communication module includes technical standards or communication methods for mobile communication (eg, GSM (Global System for Mobile communication), CDMA (Code Division Multi Access), CDMA2000 (Code Division Multi Access 2000)), EV-DO ( Enhanced Voice-Data Optimized or Enhanced Voice-Data Only), Wideband CDMA (WCDMA), High Speed Downlink Packet Access (HSDPA), High Speed Uplink Packet Access (HSUPA), Long Term Evolution (LTE), Long Term (LTE-A) Evolution-Advanced), etc.), transmits and receives radio signals to and from at least one of a base station, an external terminal, and a server on a mobile communication network.
무선 인터넷 모듈은 무선 인터넷 접속을 위한 모듈을 말하는 것으로, 사용자 단말기(100)에 내장되거나 외장될 수 있다. 무선 인터넷 모듈은 무선 인터넷 기술들에 따른 통신망에서 무선 신호를 송수신하도록 이루어진다.The wireless Internet module refers to a module for wireless Internet access, and may be built-in or external to the user terminal 100 . The wireless Internet module is configured to transmit and receive wireless signals in a communication network according to wireless Internet technologies.
무선 인터넷 기술로는, 예를 들어 WLAN(Wireless LAN), Wi-Fi(Wireless-Fidelity), Wi-Fi(Wireless Fidelity) Direct, DLNA(Digital Living Network Alliance), WiBro(Wireless Broadband), WiMAX(World Interoperability for Microwave Access), HSDPA(High Speed Downlink Packet Access), HSUPA(High Speed Uplink Packet Access), LTE(Long Term Evolution), LTE-A(Long Term Evolution-Advanced) 등이 있다.As wireless Internet technology, for example, WLAN (Wireless LAN), Wi-Fi (Wireless-Fidelity), Wi-Fi (Wireless Fidelity) Direct, DLNA (Digital Living Network Alliance), WiBro (Wireless Broadband), WiMAX (World Interoperability for Microwave Access), High Speed Downlink Packet Access (HSDPA), High Speed Uplink Packet Access (HSUPA), Long Term Evolution (LTE), Long Term Evolution-Advanced (LTE-A), and the like.
근거리 통신 모듈은 근거리 통신(Short range communication)을 위한 것으로서, 블루투스(Bluetooth™), RFID(Radio Frequency Identification), 적외선 통신(Infrared Data Association; IrDA), UWB(Ultra Wideband), ZigBee, NFC(Near Field Communication), Wi-Fi(Wireless-Fidelity), Wi-Fi Direct, Wireless USB(Wireless Universal Serial Bus) 기술 중 적어도 하나를 이용하여, 근거리 통신을 지원할 수 있다.The short-range communication module is for short-range communication, and includes Bluetooth™, Radio Frequency Identification (RFID), Infrared Data Association (IrDA), Ultra Wideband (UWB), ZigBee, and Near Field (NFC). Communication), Wi-Fi (Wireless-Fidelity), Wi-Fi Direct, and Wireless USB (Wireless Universal Serial Bus) technology may be used to support short-distance communication.
위치정보 모듈은 사용자 단말기(100)의 위치(또는 현재 위치)를 획득하기 위한 모듈로서, 그의 대표적인 예로는 GPS(Global Positioning System) 모듈 또는 WiFi(Wireless Fidelity) 모듈이 있다. 예를 들어, 단말기는 GPS모듈을 활용하면, GPS 위성에서 보내는 신호를 이용하여 사용자 단말기(100)의 위치를 획득할 수 있다. The location information module is a module for acquiring the location (or current location) of the user terminal 100 , and a representative example thereof includes a Global Positioning System (GPS) module or a Wireless Fidelity (WiFi) module. For example, if the terminal utilizes a GPS module, it may acquire the location of the user terminal 100 using a signal transmitted from a GPS satellite.
일 실시 예에서, 사용자 단말기(100)는 사용자의 약물 종류, 부작용 종류 등의 입력을 위한 입력부를 포함할 수 있다.In an embodiment, the user terminal 100 may include an input unit for inputting the user's drug type, side effect type, and the like.
입력부는 오디오 신호를 수신하기 위한 마이크로폰, 사용자로부터 정보를 입력 받기 위한 사용자 입력부를 포함할 수 있다. The input unit may include a microphone for receiving an audio signal and a user input unit for receiving information from a user.
사용자 입력부는 기계식(mechanical) 입력수단(또는, 메커니컬 키, 버튼, 돔 스위치 (dome switch), 조그 휠, 조그 스위치 등) 및 터치식 입력수단을 포함할 수 있다. 일 예로서, 터치식 입력수단은, 소프트웨어적인 처리를 통해 터치스크린에 표시되는 가상 키(virtual key), 소프트 키(soft key) 또는 비주얼 키(visual key)로 이루어지거나, 상기 터치스크린 이외의 부분에 배치되는 터치 키(touch key)로 이루어질 수 있다.The user input unit may include a mechanical input means (or a mechanical key, a button, a dome switch, a jog wheel, a jog switch, etc.) and a touch input means. As an example, the touch input means consists of a virtual key, a soft key, or a visual key displayed on the touch screen through software processing, or a part other than the touch screen. It may be made of a touch key (touch key) disposed on the.
일 실시 예에서, 사용자 단말기(100)는 사용자에게 정보를 전달하기 위한 출력부를 포함할 수 있다.In an embodiment, the user terminal 100 may include an output unit for transmitting information to the user.
출력부는 시각, 청각 또는 촉각 등과 관련된 출력을 발생시키기 위한 것으로, 디스플레이부, 음향 출력부, 광 출력부 중 적어도 하나를 포함할 수 있다. The output unit is for generating an output related to visual, auditory or tactile sense, and may include at least one of a display unit, a sound output unit, and an optical output unit.
디스플레이부는 사용자 단말기(100)에서 처리되는 정보를 표시(출력)한다. 예를 들어, 디스플레이부는 사용자가 복용한 약물과 관련하여 서버 장치(200)로부터 제공 받은 약물 또는 약물에 포함된 성분들의 부작용 종류를 표시할 수 있다. The display unit displays (outputs) information processed by the user terminal 100 . For example, the display unit may display a drug provided from the server device 200 in relation to the drug taken by the user or the type of side effects of components included in the drug.
음향 출력부는 리시버(receiver), 스피커(speaker), 버저(buzzer) 중 적어도 하나 이상을 포함할 수 있다.The sound output unit may include at least one of a receiver, a speaker, and a buzzer.
사용자 단말기(100)는 사용자 단말기(100)에 연결되는 다양한 종류의 외부 기기와의 통로 역할을 수행하는 인터페이스부를 포함할 수 있다. 인터페이스부는, 유/무선 데이터 포트(port), 메모리 카드(memory card) 포트, 식별 모듈이 구비된 장치를 연결하는 포트(port), 오디오 I/O(Input/Output) 포트(port), 비디오 I/O(Input/Output) 포트(port), 이어폰 포트(port)중 적어도 하나를 포함할 수 있다. The user terminal 100 may include an interface unit that serves as a passage with various types of external devices connected to the user terminal 100 . The interface unit includes a wired/wireless data port, a memory card port, a port for connecting a device equipped with an identification module, an audio I/O (Input/Output) port, a video I It may include at least one of an /O (Input/Output) port and an earphone port.
도 3을 참조하여 본 개시의 일 실시 예에 따른 서버 장치(200)의 구성을 설명한다.A configuration of the server device 200 according to an embodiment of the present disclosure will be described with reference to FIG. 3 .
서버 장치(200)는 대상자의 신체 정보, 대상자의 약물 처방 시의 진단명(진단 코드일 수 있다)복용한 약물의 종류 또는 약물에 포함된 성분의 종류, 각 약물을 복용한 용량 및 시간 정보, 각 약물을 복용했을 경우 경험한 부작용의 발생 여부 또는 부작용의 종류 등을 저장할 수 있다.The server device 200 includes the subject's body information, a diagnosis name (which may be a diagnostic code) when prescribing the subject's drug, the type of drug taken or the type of component included in the drug, the dose and time information of each drug, each When taking a drug, it is possible to store whether or not any side effects experienced or the type of side effects.
서버 장치(200)는 약물 또는 약물에 포함된 성분들의 통계적인 부작용 정보, 약물의 성분 정보를 저장할 수 있다.The server device 200 may store the drug or statistical side effect information of the components included in the drug, and the component information of the drug.
서버 장치(200)는 환자의 진단병명(진단 코드일 수 있다)을 포함하는 진료 정보, 처방 정보 또는 신체 정보 등을 저장할 수 있다.The server device 200 may store medical treatment information including a patient's diagnosis disease name (which may be a diagnosis code), prescription information, or body information.
서버 장치(200)가 저장한 정보들은 외부의 별도 데이터 베이스로서 구현되거나 서버 장치(200)의 일 부분인 저장 장치(240)로 구현될 수 있다.The information stored by the server device 200 may be implemented as an external separate database or may be implemented as a storage device 240 that is a part of the server device 200 .
서버 장치(200)는 사용자 단말기(100)로부터 통신 인터페이스(230)를 통해 제공 받은 사용자가 복용한 약물 종류, 부작용 발생 여부 및 부작용 종류에 기반하고 약물의 성분 정보 및 약물 또는 약물에 포함된 성분들의 통계적인 부작용 정보를 이용하여 프로세서(210)가 사용자의 개인화된 약물 부작용 확률을 산정할 수 있다. The server device 200 is based on the type of drug the user has taken, whether side effects occur, and the type of side effects, provided from the user terminal 100 through the communication interface 230, and is based on the component information of the drug and the drug or ingredients included in the drug. Using the statistical side effect information, the processor 210 may calculate the user's personalized drug side effect probability.
서버 장치(200)의 프로세서(210)는 사용자가 약물을 복용한 후 부작용의 발생뿐만 아니라 미 발생에 기반하여 사용자의 개인화된 약물 부작용 확률을 산정할 수 있고, 이 경우 사용자의 개인화된 약물 부작용 확률을 산정하는 알고리듬을 서로 다르게 적용할 수 있다.The processor 210 of the server device 200 may calculate the user's personalized drug side effect probability based on the occurrence as well as the non-occurrence of side effects after the user takes the drug, and in this case, the user's personalized drug side effect probability Algorithms for calculating ? can be applied differently.
사용자의 개인화된 약물 부작용 확률을 산정하는 알고리듬은 하드웨어, 소프트웨어 또는 하드웨어와 소프트웨어의 조합으로 구현될 수 있으며, 알고리듬의 일부 또는 전부가 소프트웨어로 구현되는 경우 알고리듬을 구성하는 하나 이상의 명령어는 메모리(220)에 저장될 수 있다.The algorithm for estimating the user's personalized drug side effect probability may be implemented in hardware, software, or a combination of hardware and software. can be stored in
도 4를 참조하여 본 개시의 일 실시 예에 따른 개인화된 약물 부작용 확률을 산정하는 방법을 설명한다.A method of calculating a personalized drug side effect probability according to an embodiment of the present disclosure will be described with reference to FIG. 4 .
앞서 전제한 것처럼 개인화된 약물 부작용 확률을 산정하는 방법은 사용자 단말기에서도 구현 가능하지만, 아래의 설명은 서버 장치에서 구현되는 것을 전제로 하여 설명한다.As previously premised, the method for estimating the personalized drug side effect probability can be implemented in the user terminal, but the following description is based on the assumption that it is implemented in the server device.
서버 장치(200)는 사용자 단말기(100)에서 사용자가 입력한 사용자가 복용한 약제를 확인한다(S110). 사용자가 복용한 약제는 단일 성분으로 구성된 약제이거나 복수의 성분으로 구성된 약제일 수 있고, 동일한 시간 또는 일정한 시간 내에 복용한 복수의 약제일 수 있다. 약제는 사용자 단말기(100)의 카메라 장치를 통해 제품 포장지의 제품명을 인식하거나 제품 포장지의 QR코드 등의 코드를 인식하거나, 사용자의 입력을 통해 입력된 제품 명일 수 있다. 또한, 서버 장치(200)는 유사한 방법으로 처방전에 인쇄된 진단명 또는 진단 코드를 확인하거나 별개의 의료 정보 시스템(OCS, HIS, EMR 등)에 접속하여 진단명 또는 진단 코드를 확인할 수 있다.The server device 200 checks the medication taken by the user input by the user in the user terminal 100 (S110). The drug taken by the user may be a drug composed of a single component or a drug composed of a plurality of components, and may be a plurality of drugs taken at the same time or within a predetermined time. The drug may be a product name input through a user input, or by recognizing a product name on a product packaging paper or by recognizing a code such as a QR code on a product packaging paper through the camera device of the user terminal 100 . In addition, the server device 200 may check a diagnosis name or a diagnosis code printed on a prescription in a similar manner, or may check a diagnosis name or a diagnosis code by accessing a separate medical information system (OCS, HIS, EMR, etc.).
서버 장치(200)는 약제의 복용에 따른 사용자의 부작용 발생 여부 또는 부작용 종류를 포함하는 부작용 경험을 확인할 수 있다(S120). The server device 200 may check whether the user has side effects according to the taking of the drug or the side effects experience including the type of side effects (S120).
서버 장치(200)는 사용자의 부작용 경험에 기반하여 복용한 개별 약제에 대한 사용자의 부작용 발생 확률을 산정한다(S130). 사용자가 해당 약제를 최초로 복용한 경우, 서버 장치(200)는 데이터 베이스에서 해당 약제 또는 해당 약제에 포함된 성분의 도 6과 같은 통계적인 부작용 확률을 획득하고 이를 해당 약제에 대한 사용자의 기본 부작용 확률로 설정하고 확인한 사용자의 부작용 경험에 기반하여 약물 부작용 확률을 산정한다.The server device 200 calculates the probability of occurrence of side effects of the user for the individual medications taken based on the user's experience of side effects (S130). When the user first takes the drug, the server device 200 obtains a statistical side effect probability as shown in FIG. 6 of the drug or a component included in the drug from the database, and determines the user's basic side effect probability for the drug The probability of drug side effects is calculated based on the user's experience of side effects set and confirmed.
부작용 경험은 부작용의 미 발생을 포함하고, 서버 장치(200)는 사용자의 특정 약제의 복용 후 부작용이 미 발생한 경험도 반영하여 사용자의 부작용 경험에 기반하여 약물 부작용 확률을 산정한다. 따라서, 서버 장치(200)는 사용자가 동일한 약제를 복용한 경험이 입력되거나 또는 동일한 성분이 포함된 약제를 복용한 경험이 입력될 때마다, 즉 약제를 복용한 후 부작용의 발생 또는 미 발생을 포함한 모든 경험에 대하여 해당 약제 또는 해당 약제에 포함된 성분에 대하여 사용자의 부작용 발생 확률을 갱신한다.The side effect experience includes the non-occurrence of side effects, and the server device 200 calculates the drug side effect probability based on the user's side effects experience by reflecting the user's experience that side effects do not occur after taking a specific drug. Therefore, the server device 200 includes the occurrence or non-occurrence of side effects after taking the drug, that is, whenever the user experiences taking the same drug or the experience of taking the drug containing the same component is input. For all experiences, the probability of occurrence of side effects of the user is updated with respect to the drug or a component included in the drug.
서버 장치(200)는 사용자가 약제를 복용한 후 부작용의 발생 또는 미 발생의 경험에 대하여 서로 다른 알고리듬을 적용하여 해당 약제에 대한 사용자의 부작용 발생 확률을 산정하며 아래에서 자세히 설명한다.The server device 200 applies different algorithms to the experience of occurrence or non-occurrence of side effects after the user takes the drug to calculate the probability of occurrence of side effects of the user with respect to the corresponding drug, which will be described in detail below.
도 5를 참조하여 본 개시의 일 실시 예에 따른 개인화된 약물 부작용 확률을 산정하는 구체적인 방법(S130)을 설명한다.A detailed method ( S130 ) of calculating a personalized drug side effect probability according to an embodiment of the present disclosure will be described with reference to FIG. 5 .
서버 장치(200)는 사용자가 약제를 복용한 후 부작용의 발생 또는 미 발생의 경험에 대하여 서로 다른 알고리듬을 적용하여 해당 약제에 대한 사용자의 부작용 발생 확률을 산정할 수 있고, 부작용이 발생하지 않은 경우 복용한 약제 또는 약제의 성분에 대하여 사용자의 부작용 발생 확률을 감소시킬 수 있다(S132).The server device 200 applies different algorithms to the experience of occurrence or non-occurrence of side effects after the user takes the drug to calculate the probability of occurrence of side effects of the user with respect to the corresponding drug, and when no side effects occur It is possible to reduce the probability of occurrence of side effects of the user with respect to the drug or component of the drug (S132).
이 경우, 서버 장치(200)는 복합 성분으로 구성된 약제이거나 복수의 약제를 복용한 경우 각 성분 별로 사용자의 부작용 발생 확률의 증감을 감소시킬 수 있다. 일 실시 예에서, 여러가지 약제를 동시에 복용한 경우에, 특정 부작용 확률을 증감하는 알고리듬은 복용한 약제의 개수로 나누어 균등히 증감하거나, 이전 부작용 발생 확률에 가중치를 부여하여 반영하는 경우 등을 포함한다.In this case, the server device 200 may reduce the increase or decrease in the probability of occurrence of side effects of the user for each component when a drug composed of a complex component or a plurality of drugs is taken. In one embodiment, in the case of taking several drugs at the same time, the algorithm for increasing or decreasing the probability of a specific side effect includes a case in which the probability of a specific side effect is increased or decreased equally by dividing by the number of drugs taken, or a weight is applied to the probability of occurrence of a previous side effect and reflected.
최초로 특정 약제를 사용자가 복용하고 부작용이 미 발생한 경우, 서버 장치(200)는 도 6과 같은 통계적인 부작용 확률을 획득하고 이를 해당 약제에 대한 사용자의 기본 부작용 확률로 설정한다. 예를 들어, 도 6을 참조하면 성분 A의 증상 1에 대한 통계적인 부작용 발생 확률은 10%이고, 증상 2에 대한 통계적인 부작용 발생 확률은 5%이다. 이후, 서버 장치(200)는 기본 부작용 확률에 사용자의 부작용 미 발생 경험을 반영하는 미리 설정된 역보상(disincentive) 상수를 곱할 수 있고, 역보상 상수는 1보다 작을 수 있으며 실험적으로 결정될 수 있다.When a user first takes a specific drug and no side effects occur, the server device 200 acquires a statistical side effect probability as shown in FIG. 6 and sets it as the user's basic side effect probability for the corresponding drug. For example, referring to FIG. 6 , the probability of occurrence of a statistical side effect for symptom 1 of component A is 10%, and the probability of occurrence of a statistical side effect for symptom 2 is 5%. Thereafter, the server device 200 may multiply the basic side effect probability by a preset disincentive constant that reflects the user's experience of not generating side effects, and the disincentive constant may be less than 1 and may be determined experimentally.
예를 들어, 역보상 상수가 0.5인 경우, 사용자가 성분 A 및 성분 B가 포함된 약제를 최초로 복용한 후 부작용이 발생하지 않은 경우, 서버 장치(200)는 사용자의 성분 A에 대한 증상 1의 부작용 발생 확률을 5%(=10% × 0.5), 증상 2의 부작용 발생 확률을 2.5%(=5% × 0.5), 성분 B에 대한 증상 1의 부작용 발생 확률을 10%(=20% × 0.5)로 산정할 수 있다.For example, when the inverse compensation constant is 0.5, when the user first takes the drug containing component A and component B, and no side effect occurs, the server device 200 determines the symptom 1 for component A of the user. 5% (=10% × 0.5) chance of adverse event occurrence, 2.5% (=5% × 0.5) chance of adverse event occurrence of symptom 2, and 10% (=20% × 0.5) chance of adverse event occurrence for symptom 1 for component B ) can be calculated as
이후, 동일한 약을 복용하여 다시 부작용이 발생하지 않은 경우, 서버 장치(200)는 이전에 산정된 사용자의 부작용 발생 확률에 기반하고 동일한 역보상 상수를 이용하여 성분 A, B의 각 증상에 대한 사용자의 부작용 발생 확률을 재 산정(갱신)할 수 있다.After that, if side effects do not occur again by taking the same drug, the server device 200 determines the user for each symptom of components A and B using the same inverse compensation constant based on the previously calculated probability of occurrence of side effects of the user. It is possible to recalculate (update) the probability of occurrence of side effects.
도 5 및 도 7 (a)를 참조하여, 부작용이 발생한 경우 사용자의 부작용 확률을 산정하는 방법을 설명한다.A method of calculating a user's side effect probability when a side effect occurs will be described with reference to FIGS. 5 and 7 ( a ).
도 7 (a)의 사용자가 최초로 성분 A 및 B가 포함된 특정 약제를 사용자가 복용하고 부작용이 발생한 경우, 서버 장치(200)는 사용자의 질환을 확인할 수 있다(S133). 서버 장치(200)는 환자의 질병 코드가 기록된 처방 정보를 EMR(Electronic Medical Record) 서버에서 확인하거나 사용자의 입력을 통하여 확인할 수 있다. EMR 서버는 공공 기관에서 관리하는 의료 기록 관리 서버뿐만 아니라 각 병원의 의료 기록을 공유하거나 전달하기 위하여 민간 기관에서 관리하는 의료 기록 관리 또는 전달 서버 등을 포함하는 개념이다. 사용자는 앞서 설명한 것처럼 처방전에서 사용자 단말기(100)의 카메라 장치를 통해 처방전에 인쇄된 질병 코드를 인식하거나 직접 입력할 수 있다.When the user of FIG. 7 (a) first takes a specific drug containing components A and B, and side effects occur, the server device 200 may check the user's disease (S133). The server device 200 may check prescription information in which the patient's disease code is recorded in an Electronic Medical Record (EMR) server or through a user's input. The EMR server is a concept including a medical record management server managed by a public institution, as well as a medical record management or delivery server managed by a private institution to share or deliver the medical records of each hospital. As described above, the user may recognize or directly input the disease code printed on the prescription through the camera device of the user terminal 100 from the prescription.
서버 장치(200)는 사용자의 질병의 증상을 확인하고(S134), 환자가 복용한 약제 또는 약제의 도 6과 같은 통계적인 부작용 확률을 획득하여, 서로 비교할 수 있다(S135). 서버 장치(200)는 사용자의 질병의 증상과 복용한 약제의 부작용이 동일한 경우 해당 부작용 경험은 사용자의 약물 부작용 확률 산정에 반영하지 않을 수 있다. 따라서, 사용자가 질병의 증상을 약제 복용으로 인한 부작용 발생으로 오인함으로써 부작용 확률을 잘못 산정하는 경우를 배제할 수 있다.The server device 200 may check the symptoms of the user's disease (S134), obtain the statistical side effect probability of the drug or the drug taken by the patient as shown in FIG. 6, and compare them with each other (S135). When the symptoms of the user's disease and the side effects of the drug taken are the same, the server device 200 may not reflect the corresponding side effect experience in calculating the user's drug side effect probability. Accordingly, it is possible to exclude a case in which the user incorrectly calculates the probability of a side effect by mistaking the symptom of a disease as the occurrence of a side effect due to taking the drug.
사용자의 질병의 증상과 복용한 약제의 부작용이 서로 다른 경우, 서버 장치(200)는 복용한 약제의 성분 별로 사용자의 부작용 발생 확률을 증가시킬 수 있다(S136). When the symptoms of the user's disease and the side effects of the medication are different from each other, the server device 200 may increase the probability of occurrence of the side effects of the user for each component of the medication taken (S136).
최초로 특정 약제를 사용자가 복용하고 부작용이 미 발생한 경우, 서버 장치(200)는 도 6과 같은 통계적인 부작용 확률을 획득하고 이를 해당 약제에 대한 사용자의 기본 부작용 확률로 설정한 후, 서버 장치(200)는 기본 부작용 확률에 사용자의 부작용 발생 경험을 반영하는 미리 설정된 보상(incentive) 상수를 곱할 수 있고, 보상 상수는 1보다 클 수 있으며 실험적으로 결정될 수 있다.When a user takes a specific drug for the first time and side effects do not occur, the server device 200 obtains a statistical side effect probability as shown in FIG. 6 and sets it as the user's basic side effect probability for the corresponding drug, and then the server device 200 ) may be multiplied by a preset incentive constant that reflects the user's experience in generating side effects to the basic side effect probability, and the reward constant may be greater than 1 and may be determined experimentally.
예를 들어, 보상 상수가 1.5인 경우, 도 7(a)의 사용자가 성분 A 및 성분 B가 포함된 약제를 최초로 복용한 후 증상 1 및 증상 2가 발생한 경우를 설명한다. 서버 장치(200)는 사용자의 성분 A에 대한 증상 1의 부작용 발생 확률을 15%(=10% × 1.5), 성분 A에 대한 증상 2의 부작용 발생 확률을 7.5%(=5% × 1.5), 성분 B에 대한 증상 1의 부작용 발생 확률을 30%(=20% × 1.5)로 산정할 수 있다. 증상 2는 성분 B의 통계적인 부작용이 아니므로 부작용 발생 확률을 산정하지 않을 수 있다.For example, when the compensation constant is 1.5, a case in which symptoms 1 and 2 occurs after the user of FIG. 7 (a) first takes a drug containing component A and component B will be described. The server device 200 increases the probability of occurrence of side effects of symptom 1 for component A by 15% (=10% × 1.5), and the probability of occurrence of side effects of symptom 2 for component A by 7.5% (=5% × 1.5), The probability of occurrence of the side effect of symptom 1 for component B can be estimated as 30% (=20% × 1.5). Since symptom 2 is not a statistical side effect of component B, the probability of occurrence of side effects may not be calculated.
도 7(a)의 사용자와 같은 사용자가 가 성분 A 및 성분 B가 포함된 동일한 약제를 다시 복용하거나 성분 A 및 성분 B가 포함된 다른 약제를 복용한 후 도 7 (b)와 같이 증상 1이 발생하고 증상 2가 미 발생한 경우에 대하여 약물 부작용 확률을 재 산정(갱신)하는 방법을 설명한다.After a user, such as the user of FIG. 7(a), takes the same drug containing component A and component B again, or takes another drug containing component A and component B, as shown in FIG. 7(b), symptom 1 is The method of recalculating (updating) the probability of drug side effects for the case where symptom 2 has not occurred will be described.
보상 상수가 1.5이고 역보상 상수가 0.5인 경우, 도 7(b)의 사용자는 이전에 경험한 성분 A 및 성분 B가 포함된 약제를 다시 복용한 후 증상 1이 발생하고 증상 2가 미 발생한 경우이다. 서버 장치(200)는 사용자의 저장된 성분 A 및 성분 B에 대한 부작용 확률에 역보상 상수 및 보상 상수를 적용하여 약물 부작용 확률을 갱신할 수 있다.When the compensation constant is 1.5 and the inverse compensation constant is 0.5, when the user of FIG. 7(b) takes the drug containing component A and component B again, symptom 1 occurs and symptom 2 does not occur to be. The server device 200 may update the drug side effect probability by applying the inverse compensation constant and the compensation constant to the user's stored side effect probability for component A and component B.
예를 들어, 서버 장치(200)는 성분 A에 대한 증상 1의 부작용 발생 확률을 22.5%(=15% × 1.5), 성분 A에 대한 증상 2의 부작용 발생 확률을 3.75%(=7.5% × 0.5), 성분 B에 대한 증상 1의 부작용 발생 확률을 45%(=30% × 1.5)로 산정할 수 있다. 증상 2는 성분 B의 통계적인 부작용이 아니므로 부작용 발생 확률을 산정하지 않을 수 있다.For example, the server device 200 increases the probability of occurrence of the side effect of symptom 1 for component A by 22.5% (=15% × 1.5), and the probability of occurrence of the side effect of symptom 2 for component A by 3.75% (=7.5% × 0.5) ), the probability of occurrence of the side effect of symptom 1 for component B can be estimated as 45% (=30% × 1.5). Since symptom 2 is not a statistical side effect of component B, the probability of occurrence of side effects may not be calculated.
다시 도 7(b)의 사용자가 성분 A를 포함하는 다른 약제를 복용한 후 약물 부작용 발생 확률을 갱신하는 것을 설명한다. 도 7(b)의 사용자와 같은 사용자가 가 성분 A 및 성분 C가 포함된 다른 약제 'b'를 다시 복용한 후 도 8 (b)와 같이 증상 1이 발생하고 증상 2가 미 발생한 경우에 대하여 약물 부작용 확률을 재 산정(갱신)하는 방법을 설명한다.Again, it will be described that the user of FIG. 7(b) updates the drug side effect occurrence probability after taking another drug containing component A. For the case where symptom 1 occurs and symptom 2 does not occur as shown in FIG. 8 (b) after a user, such as the user of FIG. Methods for reestimating (updating) the probability of adverse drug reactions are described.
현재 사용자 '가'에 대하여 기 저장된 성분 A의 증상 1에 대한 개인화된 부작용 확률인 22.5%에 보상 상수 1.5를 적용하여 개인화된 부작용 확률이 33.75%의 부작용 확률로 갱신될 수 있고, 기 저장된 성분 A의 증상 2에 대한 개인화된 부작용 확률인 3.75%에 역 보상 상수 0.5를 적용하여 개인화된 부작용 확률이 1.875%의 부작용 확률로 갱신될 수 있다. 또한, 약제 'b'에 포함된 성분 C는 최초 복용한 경우 성분 C의 증상 1에 대한 통계적인 부작용 확률 10%에 보상 상수 1.5를 적용하여 성분 C에 대한 개인화된 부작용 확률을 15%로 산정할 수 있다.By applying the reward constant 1.5 to the personalized side effect probability of 22.5% for symptom 1 of component A stored in advance for the current user 'A', the personalized side effect probability can be updated to a side effect probability of 33.75%, and the pre-stored component A By applying the inverse reward constant 0.5 to the personalized side effect probability of 3.75% for symptom 2 of , the personalized side effect probability can be updated with a side effect probability of 1.875%. In addition, when component C included in drug 'b' is taken for the first time, the reward constant 1.5 is applied to 10% of the statistical side effect probability for symptom 1 of component C to calculate the personalized side effect probability for component C as 15%. can
다른 실시 예에서, 데이터 베이스에 해당 약제 또는 해당 약제에 포함된 성분의 통계적인 부작용 확률 값이 존재하지 않는 경우, 구현의 측면에서 임의의 특정 상수 값(매우 작을 수 있다)으로 초기 값을 설정할 수 있다.In another embodiment, if there is no statistical side effect probability value of the drug or a component included in the drug in the database, the initial value may be set to an arbitrary specific constant value (which may be very small) in terms of implementation. have.
위와 같은 방법을 통하여, 사용자는 일부의 성분이 겹치는 서로 다른 약물들을 복용한 경험이 누적될수록 개인화된 부작용 발생 확률을 획득하고, 이에 기반하여 회피할 약물을 결정할 수 있다.Through the above method, the user can acquire a personalized side effect occurrence probability as the experience of taking different drugs with some overlapping components is accumulated, and determine the drug to avoid based on this.
다른 실시 예에서, 서버 장치(200)는 약물 또는 약물에 포함된 성분의 통계적인 부작용 확률에 기반하여 보상 상수를 성분마다 서로 다르게 설정할 수 있다.In another embodiment, the server device 200 may set the compensation constant differently for each component based on the statistical side effect probability of the drug or a component included in the drug.
예를 들어, 약물에 포함된 성분의 통계적인 부작용 확률이 도 6과 같은 경우, 성분 A의 증상 1에 대한 보상 상수는 성분 B의 증상 1에 대한 보상 상수보다 낮게 설정할 수 있다. 따라서, 동일한 부작용 증상을 가진 복수의 성분들에 대해서도 서로 다른 통계적 확률을 반영하여 개인화된 부작용 발생 확률을 획득할 수 있다.For example, when the statistical side effect probability of a component included in the drug is as shown in FIG. 6 , the compensation constant for symptom 1 of component A may be set lower than the compensation constant for symptom 1 of component B. Accordingly, it is possible to obtain a personalized side effect occurrence probability by reflecting different statistical probabilities even for a plurality of components having the same side effect symptom.
다른 실시 예에서, 서버 장치(200)는 사용자의 동일한 성분을 복용한 후 동일한 부작용이 발생한 경험의 연속된 횟수에 기반하여 보상 상수를 서로 다르게 설정할 수 있다.In another embodiment, the server device 200 may set the compensation constant differently based on the consecutive number of times the user experiences the same side effect after taking the same ingredient.
예를 들어, 서버 장치(200)는 성분 A의 증상 1을 첫 번째로 경험했을 때의 보상 상수보다 성분 A의 증상 1을 연속하여 두 번째로 경험했을 때의 보상 상수를 더 크게 설정할 수 있다. 따라서, 서로 다른 약물들을 복용한 경험이 누적될수록 보다 정밀하게 개인화된 부작용 발생 확률을 획득할 수 있다.For example, the server device 200 may set a compensation constant when symptom 1 of component A is continuously experienced a second time to be larger than a compensation constant when symptom 1 of component A is first experienced. Therefore, as the experience of taking different drugs is accumulated, it is possible to obtain a more precisely personalized probability of occurrence of side effects.
다른 실시 예에서, 서버 장치(200)는 사용자가 경험한 부작용의 강도에 기반하여 보상 상수를 서로 다르게 설정할 수 있다.In another embodiment, the server device 200 may set the compensation constant differently based on the intensity of the side effect experienced by the user.
*예를 들어, 서버 장치(200)는 성분 A의 증상 1을 강도 1로 경험했을 때의 보상 상수보다 성분 A의 증상 1을 강도 2로 경험했을 때의 보상 상수를 더 크게 설정할 수 있다. 서버 장치(200)는 사용자 단말기(100)에 사용자가 경험한 부작용의 강도를 선택할 수 있는 인터페이스를 제공할 수 있다. 따라서, 약물들을 복용한 경험이 누적될수록 보다 정밀하게 개인화된 부작용 발생 확률을 획득할 수 있다.*For example, the server device 200 may set the compensation constant when the symptom 1 of the component A is experienced with the intensity 2 to be larger than the compensation constant when the symptom 1 of the component A is experienced with the intensity 1. The server device 200 may provide the user terminal 100 with an interface for selecting the intensity of the side effect experienced by the user. Accordingly, as the experience of taking drugs is accumulated, it is possible to obtain a more precisely personalized probability of occurrence of side effects.
다른 실시 예에서, 서버 장치(200)는 사용자가 이전에 복용한 약물의 약물 혈중 농도가 특정 레벨 이상인 경우, 즉 이전에 복용한 약물이 체내에 잔존하는 것으로 판단한 경우, 약물의 부작용 확률 산정을 위한 경험에서 배제할 수 있다.In another embodiment, when the drug blood concentration of the drug previously taken by the user is higher than or equal to a certain level, that is, when it is determined that the drug previously taken remains in the body, the server device 200 is for calculating the probability of side effects of the drug. can be excluded from experience.
예를 들어, 서버 장치(200)는 사용자가 이전에 성분 A가 포함된 약제를 복용한 시간을 확인하고, 미리 설정된 사용자의 신체 정보에 기반하여 성분 A의 혈중 농도를 계산하고 혈중 농도가 미리 설정된 기준 이상인 경우 부작용이 발생하였더라도 이를 약물의 부작용 확률 산정을 위한 경험에서 배제할 수 있다. 따라서, 이전 복용으로 인하여 부작용 경험이 중복적으로 적용되어 약물의 부작용 확률이 높아지는 것을 배제할 수 있다.For example, the server device 200 checks the time the user previously took the drug containing component A, calculates the blood concentration of component A based on the user's body information set in advance, and the blood concentration is preset In the case of exceeding the standard, even if a side effect occurs, it can be excluded from the experience for estimating the probability of a drug side effect. Therefore, it is possible to exclude that the side effects experience of the drug is increased due to the overlapping experience of side effects due to the previous administration.
전술한 본 개시는, 프로그램이 기록된 매체에 컴퓨터가 읽을 수 있는 코드로서 구현하는 것이 가능하다. 컴퓨터가 읽을 수 있는 매체는, 컴퓨터 시스템에 의하여 읽혀질 수 있는 데이터가 저장되는 모든 종류의 기록장치를 포함한다. 컴퓨터가 읽을 수 있는 매체의 예로는, HDD(Hard Disk Drive), SSD(Solid State Disk), SDD(Silicon Disk Drive), ROM, RAM, CD-ROM, 자기 테이프, 플로피 디스크, 광 데이터 저장 장치 등이 있다. 또한, 상기 컴퓨터는 사용자 단말기 또는 서버 장치의 프로세서를 포함할 수도 있다.The present disclosure described above can be implemented as computer-readable code on a medium in which a program is recorded. The computer-readable medium includes all types of recording devices in which data readable by a computer system is stored. Examples of computer-readable media include Hard Disk Drive (HDD), Solid State Disk (SSD), Silicon Disk Drive (SDD), ROM, RAM, CD-ROM, magnetic tape, floppy disk, optical data storage device, etc. There is this. In addition, the computer may include a processor of a user terminal or a server device.
한편, 상기 프로그램은 본 개시를 위하여 특별히 설계되고 구성된 것이거나 컴퓨터 소프트웨어 분야의 통상의 기술자에게 공지되어 사용 가능한 것일 수 있다. 프로그램의 예에는, 컴파일러에 의하여 만들어지는 것과 같은 기계어 코드뿐만 아니라 인터프리터 등을 사용하여 컴퓨터에 의해서 실행될 수 있는 고급 언어 코드도 포함될 수 있다.Meanwhile, the program may be specially designed and configured for the present disclosure, or may be known and used by those skilled in the art of computer software. Examples of the program may include not only machine code generated by a compiler, but also high-level language code that can be executed by a computer using an interpreter or the like.
본 개시의 명세서(특히 특허청구범위에서)에서 "상기"의 용어 및 이와 유사한 지시 용어의 사용은 단수 및 복수 모두에 해당하는 것일 수 있다. 또한, 본 개시에서 범위(range)를 기재한 경우 상기 범위에 속하는 개별적인 값을 적용한 발명을 포함하는 것으로서(이에 반하는 기재가 없다면), 발명의 상세한 설명에 상기 범위를 구성하는 각 개별적인 값을 기재한 것과 같다. In the specification of the present disclosure (especially in the claims), the use of the term “above” and similar referential terms may be used in both the singular and the plural. In addition, when a range is described in the present disclosure, each individual value constituting the range is described in the detailed description of the invention as including the invention to which individual values within the range are applied (unless there is a description to the contrary). same as
본 개시에 따른 방법을 구성하는 단계들에 대하여 명백하게 순서를 기재하거나 반하는 기재가 없다면, 상기 단계들은 적당한 순서로 행해질 수 있다. 반드시 상기 단계들의 기재 순서에 따라 본 개시가 한정되는 것은 아니다. 본 개시에서 모든 예들 또는 예시적인 용어(예들 들어, 등등)의 사용은 단순히 본 개시를 상세히 설명하기 위한 것으로서 특허청구범위에 의해 한정되지 않는 이상 상기 예들 또는 예시적인 용어로 인해 본 개시의 범위가 한정되는 것은 아니다. 또한, 통상의 기술자는 다양한 수정, 조합 및 변경이 부가된 특허청구범위 또는 그 균등물의 범주 내에서 설계 조건 및 인자(factor)에 따라 구성될 수 있음을 알 수 있다.The steps constituting the method according to the present disclosure may be performed in an appropriate order unless the order is explicitly stated or there is no description to the contrary. The present disclosure is not necessarily limited to the order in which the steps are described. The use of all examples or exemplary terminology (eg, etc.) in the present disclosure is merely for the purpose of describing the present disclosure in detail, and the scope of the present disclosure is limited by the examples or exemplary terms unless defined by the claims. it is not going to be In addition, those skilled in the art will appreciate that various modifications, combinations and changes can be made according to design conditions and factors within the scope of the appended claims or their equivalents.
따라서, 본 개시의 사상은 상기 설명된 실시 예에 국한되어 정해져서는 아니 되며, 후술하는 특허청구범위뿐만 아니라 이 특허청구범위와 균등한 또는 이로부터 등가적으로 변경된 모든 범위는 본 개시의 사상의 범주에 속한다고 할 것이다.Accordingly, the spirit of the present disclosure should not be limited to the above-described embodiments, and the scope of the spirit of the present disclosure as well as the claims to be described later are equivalent to or equivalently changed therefrom. will be said to belong to

Claims (17)

  1. 각 단계가 컴퓨팅 장치에 의해 수행되는 방법으로서,A method in which each step is performed by a computing device, the method comprising:
    대상자가 복용한 약제를 확인하는 단계;confirming the drug taken by the subject;
    상기 대상자의 상기 약제의 복용에 따른 상기 대상자로부터 입력 받은 부작용의 경험을 확인하는 단계;confirming the experience of side effects received from the subject according to the subject's taking the drug;
    상기 대상자의 상기 부작용의 경험에 기반하여 상기 약제와 관련하여 상기 대상자의 부작용의 발생 확률을 산정하는 단계를 포함하는,Comprising the step of calculating the probability of occurrence of the side effect of the subject in relation to the drug based on the subject's experience of the side effect,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  2. 제1 항에 있어서,According to claim 1,
    상기 약제와 관련하여 상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계는,The step of calculating the probability of occurrence of the side effect of the subject in relation to the drug,
    상기 대상자가 상기 약제를 복용한 경험이 입력될 때마다 상기 부작용의 발생 확률을 갱신하는 단계를 포함하는,Including the step of updating the probability of occurrence of the side effect whenever the subject's experience of taking the drug is input,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  3. 제2 항에 있어서,3. The method of claim 2,
    상기 부작용의 발생 확률을 갱신하는 단계는,The step of updating the probability of occurrence of the side effect comprises:
    상기 대상자가 상기 약제를 복용한 후 입력한 부작용의 미 발생 경험에 기반하여 상기 부작용의 발생 확률을 갱신하는 단계를 포함하는,Comprising the step of updating the probability of occurrence of the side effect based on the experience of non-occurrence of the side effect input after the subject took the drug,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  4. 제2 항에 있어서,3. The method of claim 2,
    상기 부작용의 발생 확률을 갱신하는 단계는,The step of updating the probability of occurrence of the side effect comprises:
    상기 대상자가 상기 약제를 복용한 후 입력한 부작용의 발생 여부에 따라, 서로 다른 알고리듬을 적용하여 상기 대상자의 상기 부작용의 발생 확률을 갱신하는 단계를 포함하는,Comprising the step of updating the probability of occurrence of the side effect of the subject by applying different algorithms according to whether the side effect inputted after the subject has taken the drug,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  5. 제1 항에 있어서,According to claim 1,
    상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계는,The step of calculating the probability of occurrence of the side effect of the subject,
    상기 대상자가 앓고 있는 제1 질병을 확인하는 단계; identifying a first disease afflicted by the subject;
    상기 제1 질병의 제1 증상을 확인하는 단계; 및identifying a first symptom of the first disease; and
    상기 제1 증상과 상기 부작용의 일치 여부에 기반하여 상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계를 포함하는,Comprising the step of calculating the probability of occurrence of the side effect of the subject based on whether the first symptom and the side effect match,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  6. 제5 항에 있어서,6. The method of claim 5,
    상기 제1 증상과 상기 부작용의 일치 여부에 기반하여 상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계는,The step of calculating the probability of occurrence of the side effect of the subject based on whether the first symptom and the side effect match,
    상기 제1 증상과 상기 부작용이 일치하지 않는 경우, 상기 약제에 포함된 적어도 하나의 성분을 확인하는 단계;when the first symptom and the side effect do not match, identifying at least one component included in the drug;
    약물 데이터베이스에서 획득한 상기 약제에 포함된 제1 성분의 부작용과 상기 대상자가 입력한 상기 부작용의 일치 여부를 확인하는 단계; 및checking whether the side effects of the first component included in the drug obtained from the drug database match the side effects input by the subject; and
    상기 제1 성분의 부작용 정보와 상기 대상자의 상기 부작용이 일치하는 경우, 상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계를 포함하는,When the side effect information of the first component and the side effect of the subject match, comprising the step of increasing the probability of occurrence of the side effect for the first component of the subject,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  7. 제6 항에 있어서,7. The method of claim 6,
    상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계는, The step of increasing the probability of occurrence of the side effect for the first component of the subject,
    약물 데이터베이스에서 획득한 상기 약제에 포함된 제1 성분의 부작용의 통계적 확률에 기반하여 상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계를 포함하는,Comprising the step of increasing the probability of occurrence of the side effect for the first component of the subject based on the statistical probability of the side effect of the first component contained in the drug obtained from the drug database,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  8. 제6 항에 있어서,7. The method of claim 6,
    상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계는, The step of increasing the probability of occurrence of the side effect for the first component of the subject,
    상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 경험의 연속된 횟수에 기반하여 상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계를 포함하는,increasing the probability of occurrence of the side effect for the first component in the subject based on a consecutive number of times the subject experiences the occurrence of the side effect for the first component;
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법. A method for estimating the probability of a personalized drug side effect on a computing device.
  9. 제6 항에 있어서,7. The method of claim 6,
    상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계는,The step of increasing the probability of occurrence of the side effect for the first component of the subject,
    상기 대상자가 입력한 상기 부작용의 강도를 확인하는 단계; 및confirming the intensity of the side effect input by the subject; and
    상기 부작용의 강도에 기반하여 상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키는 단계를 포함하는,increasing the probability of occurrence of the side effect for the first component in the subject based on the intensity of the side effect;
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  10. 제5 항에 있어서,6. The method of claim 5,
    상기 제1 증상과 상기 부작용의 일치 여부에 기반하여 상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계는,The step of calculating the probability of occurrence of the side effect of the subject based on whether the first symptom and the side effect match,
    상기 제1 증상과 상기 부작용이 일치하지 않는 경우, 상기 약제에 포함된 적어도 하나의 성분을 확인하는 단계;when the first symptom and the side effect do not match, identifying at least one component included in the drug;
    약물 데이터베이스에서 획득한 상기 약제에 포함된 제1 성분의 부작용과 상기 대상자가 입력한 상기 부작용의 일치 여부를 확인하는 단계; 및checking whether the side effects of the first component included in the drug obtained from the drug database match the side effects input by the subject; and
    상기 대상자가 이전에 상기 제1 성분이 포함된 약제를 복용한 시간으로부터 도과된 시간 및 상기 대상자의 신체 정보에 기반하여 상기 제1 성분의 이전 복용으로 인한 약물 혈중 농도를 계산하고, 상기 약물 혈중 농도에 기반하여 상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계를 포함하는,Calculate the drug blood concentration due to the previous dose of the first ingredient based on the time elapsed from the time when the subject previously took the drug containing the first ingredient and the subject's body information, and the drug blood concentration Comprising the step of calculating the probability of occurrence of the side effect of the subject based on
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법. A method for estimating the probability of a personalized drug side effect on a computing device.
  11. 제1 항에 있어서,According to claim 1,
    상기 대상자의 상기 부작용의 발생 확률을 산정하는 단계는,The step of calculating the probability of occurrence of the side effect of the subject,
    상기 대상자로부터 상기 약제의 복용에 따른 상기 부작용의 발생이 없는 것으로 입력된 경우, 상기 약제에 포함된 적어도 하나의 성분에 대한 상기 대상자의 상기 부작용의 발생 확률을 감소시키는 단계를 포함하는,When it is input from the subject that there is no occurrence of the side effect according to the taking of the drug, reducing the probability of occurrence of the side effect of the subject with respect to at least one component included in the drug,
    컴퓨팅 장치의 개인화된 약물 부작용 확률 산정 방법.A method for estimating the probability of a personalized drug side effect on a computing device.
  12. 프로세서; 및processor; and
    상기 프로세서와 기능적으로 연결되고, 상기 프로세서에서 수행되는 적어도 하나의 코드가 저장되는 메모리를 포함하고,It is functionally connected to the processor and includes a memory in which at least one code executed by the processor is stored,
    상기 메모리는 상기 프로세서에서 실행될 때 상기 프로세서로 하여금 대상자가 복용한 약제를 확인하고, 상기 대상자의 상기 약제의 복용에 따른 상기 대상자로부터 입력 받은 부작용의 발생을 확인하고, 상기 대상자의 상기 부작용의 경험에 기반하여 상기 약제와 관련하여 상기 대상자의 부작용의 발생 확률을 산정하도록 야기하는 코드를 저장하는,The memory, when executed in the processor, causes the processor to check the medication taken by the subject, check the occurrence of a side effect received from the subject according to the subject's taking the medication, and respond to the subject's experience of the side effect. storing a code that causes to calculate the probability of occurrence of a side effect of the subject in relation to the drug based on,
    컴퓨팅 장치.computing device.
  13. 제12 항에 있어서,13. The method of claim 12,
    상기 메모리는 상기 프로세서에서 실행될 때 상기 프로세서로 하여금 상기 대상자가 상기 약제를 복용한 경험이 입력될 때마다 상기 부작용의 발생 확률을 갱신하도록 야기하는 코드를 더 저장하는,the memory further stores code that, when executed in the processor, causes the processor to update the probability of occurrence of the side effect whenever the subject's experience of taking the medicament is input;
    컴퓨팅 장치.computing device.
  14. 제13 항에 있어서,14. The method of claim 13,
    상기 메모리는 상기 프로세서에서 실행될 때 상기 프로세서로 하여금 상기 대상자가 상기 약제를 복용한 후 입력한 부작용의 발생 여부에 따라, 서로 다른 알고리듬을 적용하여 상기 대상자의 상기 부작용의 발생 확률을 갱신하도록 야기하는 코드를 더 저장하는, The memory is a code that, when executed in the processor, causes the processor to update the probability of occurrence of the side effect of the subject by applying different algorithms according to whether the side effect inputted by the subject after taking the drug occurs to save more,
    컴퓨팅 장치.computing device.
  15. 제12 항에 있어서,13. The method of claim 12,
    상기 메모리는 상기 프로세서에서 실행될 때 상기 프로세서로 하여금 상기 대상자가 앓고 있는 제1 질병의 제1 증상과 상기 부작용의 일치 여부에 기반하여 상기 대상자의 상기 부작용의 발생 확률을 산정하도록 야기하는 코드를 더 저장하는,the memory further stores code that, when executed in the processor, causes the processor to calculate a probability of occurrence of the side effect in the subject based on whether the side effect matches a first symptom of a first disease afflicted by the subject doing,
    컴퓨팅 장치.computing device.
  16. 제15 항에 있어서,16. The method of claim 15,
    상기 메모리는 상기 프로세서에서 실행될 때 상기 프로세서로 하여금 상기 제1 증상과 상기 부작용이 일치하지 않고, 상기 약제에 포함된 적어도 하나의 성분의 부작용 정보와 상기 대상자의 상기 부작용이 일치하는 경우, 상기 대상자의 상기 제1 성분에 대한 상기 부작용의 발생 확률을 증가시키도록 야기하는,When the memory is executed in the processor, the processor causes the first symptom and the side effect to not match, and when the side effect information of at least one component included in the drug matches the side effect of the subject, the subject's causing an increase in the probability of occurrence of the side effect on the first component;
    컴퓨팅 장치.computing device.
  17. 제12 항에 있어서,13. The method of claim 12,
    상기 메모리는 상기 프로세서에서 실행될 때 상기 프로세서로 하여금 상기 대상자로부터 상기 약제의 복용에 따른 상기 부작용의 발생이 없는 것으로 입력된 경우, 상기 약제에 포함된 적어도 하나의 성분에 대한 상기 대상자의 상기 부작용의 발생 확률을 감소시키도록 야기하는 코드를 더 저장하는,When the memory is executed in the processor, when it is input by the processor that there is no occurrence of the side effect according to the taking of the drug from the subject, the occurrence of the side effect of the subject for at least one component included in the drug further storing the code causing to reduce the probability,
    컴퓨팅 장치.computing device.
PCT/KR2021/020126 2020-12-30 2021-12-29 Method and device for calculating individualized probability of medication side effect WO2022146015A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202180094842.6A CN116888681A (en) 2020-12-30 2021-12-29 Method and device for calculating individuation probability of side effect of medicine
US18/345,630 US20240013930A1 (en) 2020-12-30 2023-06-30 Apparatus and method for estimating personalized probability of drug side effects

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200187377A KR102656669B1 (en) 2020-12-30 2020-12-30 Apparatus and method for estimating the personalized probability of drug side effects
KR10-2020-0187377 2020-12-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/345,630 Continuation US20240013930A1 (en) 2020-12-30 2023-06-30 Apparatus and method for estimating personalized probability of drug side effects

Publications (1)

Publication Number Publication Date
WO2022146015A1 true WO2022146015A1 (en) 2022-07-07

Family

ID=82260667

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/020126 WO2022146015A1 (en) 2020-12-30 2021-12-29 Method and device for calculating individualized probability of medication side effect

Country Status (4)

Country Link
US (1) US20240013930A1 (en)
KR (2) KR102656669B1 (en)
CN (1) CN116888681A (en)
WO (1) WO2022146015A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102507211B1 (en) 2022-08-19 2023-03-06 김준형 Side Effect of Drug Causality Assessment Device, Side Effect of Drug Analysis Method, and Medium Being Recorded with Program for Executing the Method
KR102609482B1 (en) * 2022-09-27 2023-12-05 강민규 METHOD AND APPARATUS FOR DETECTING ADVERSE DRUG USING PERSONALIZED SIDE-EFFECT DATA AND Providing optimized personalized medications
KR102489445B1 (en) * 2022-09-29 2023-01-18 김응호 Method, device and system for testing allergy ingredient using wearable device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080042256A (en) * 2006-11-09 2008-05-15 아주대학교산학협력단 Adverse dug events surveillance system
KR20090071564A (en) * 2006-08-22 2009-07-01 리드 홀스 테크놀로지스 인코포레이티드 Medical assessment support system and method
US20130268288A1 (en) * 2010-06-28 2013-10-10 Nec Corporation Device, method, and program for extracting abnormal event from medical information using feedback information
KR20140048673A (en) * 2012-10-16 2014-04-24 안형준 Medicine retrieval system minimized individual side-effects based on private single nucleotide polymorphism and the method thereof
JP2018147463A (en) * 2017-03-02 2018-09-20 茂樹 扇谷 System and method for inspecting risk of developing adverse drug reaction, and computer program

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190054762A (en) * 2017-11-14 2019-05-22 주식회사 유비케어 Method and system for managing side effects of prescription drugs
KR20200136950A (en) 2018-03-23 2020-12-08 바이오사인즈 피티이 리미티드 Systems and methods for personalized drug treatment management

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090071564A (en) * 2006-08-22 2009-07-01 리드 홀스 테크놀로지스 인코포레이티드 Medical assessment support system and method
KR20080042256A (en) * 2006-11-09 2008-05-15 아주대학교산학협력단 Adverse dug events surveillance system
US20130268288A1 (en) * 2010-06-28 2013-10-10 Nec Corporation Device, method, and program for extracting abnormal event from medical information using feedback information
KR20140048673A (en) * 2012-10-16 2014-04-24 안형준 Medicine retrieval system minimized individual side-effects based on private single nucleotide polymorphism and the method thereof
JP2018147463A (en) * 2017-03-02 2018-09-20 茂樹 扇谷 System and method for inspecting risk of developing adverse drug reaction, and computer program

Also Published As

Publication number Publication date
KR102656669B1 (en) 2024-04-12
CN116888681A (en) 2023-10-13
US20240013930A1 (en) 2024-01-11
KR20240049792A (en) 2024-04-17
KR20220097601A (en) 2022-07-08

Similar Documents

Publication Publication Date Title
WO2022146015A1 (en) Method and device for calculating individualized probability of medication side effect
WO2014035182A1 (en) Method and apparatus for personal medical treatment using mobile terminal
US20210251486A1 (en) System and method for integration of telemedicine into multimedia video visitation systems in correctional facilities
US8943556B2 (en) Secure information release
WO2016099871A1 (en) Wireless beacon devices used to track medical information at a hospital
US20110288880A1 (en) Targeted health care messaging
WO2019139325A1 (en) Method and system for clinical trial resource management using block chain
US20120065995A1 (en) System and method for providing electronic records
JP6570691B1 (en) Personal medical information collection system
WO2015020334A1 (en) Method for providing qr code-based service for checking for occurrence of cocktail effect of drugs using smart device
WO2020108111A1 (en) Medical insurance fraud behavior identification method, apparatus, device and readable storage medium
JP7215671B2 (en) Disease diagnosis/treatment/prevention system
WO2020121606A1 (en) Personal medical information system
EP4167173A1 (en) Information system, information terminal, immunity certificate management system, information processing method, and non-transitory computer-readable medium
CN208796675U (en) A kind of information processing unit
JPWO2019130495A1 (en) Computer system, drug proposal method and program
WO2017061658A1 (en) Remote medical information communication method and system using mobile communication terminal
WO2013133610A1 (en) Method and apparatus for providing personal health record information
WO2019130494A1 (en) Computer system, alert method, and program
JP7467392B2 (en) Information providing device, worker terminal and computer program
JP2008310574A (en) Side effect information management system, side effect information management method, side effect information management program
WO2024117724A1 (en) Medical information provision system through individual patient-specific medical information provision settings
WO2022071616A1 (en) Online community-based method for analyzing medical data
KR20150134555A (en) System and method for patient medical treatment
WO2022191412A1 (en) Electronic apparatus and control method therefor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21915813

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 202180094842.6

Country of ref document: CN

122 Ep: pct application non-entry in european phase

Ref document number: 21915813

Country of ref document: EP

Kind code of ref document: A1